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Abstract	  
A Radical Cascade Approach to the Skeleton of α−Cyclopiazonic Acid. 
 
3-Nitrophthalic acid 2.04 was transformed into 2.10 in 38% yield. Vinylglycine 
derivative was synthesised from D-Methionine 2.12 in 42% yield.  
 
 
Compounds 2.10 and 2.16 were coupled using Grubbs’ 2nd generation catalyst 
creating 2.25. Unfortunately attempts to oxidise the benzylic position were 
unsuccessful. 
 
An alternative approach was investigated using diene 2.40 derived from a precursor to 
2.10 and allyl bromide 2.35. Attempts to displace bromide under anionic conditions 
were futile. The use of palladium formed conjugated dieneamine 2.65. 
 
Deprotection, oxidation and elaboration of 2.10 prior to cross metathesis allowed the 
synthesis of 2.114, which when subjected to radical conditions, formed a 
diastereomeric mixture of 2.220. 
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1.1	  Background	  
The indolic pentacyclic alkaloid α-cyclopiazonic acid (α−CPA) 1 is a mycotoxic 
secondary metabolite of the fungus Penicllium cyclopium Westling;1 it has global 
distribution, frequently isolated from stored grains and cereals.2, 3 There have been 
reports of outbreaks of disease upon ingestion of feed contaminated with P. 
cyclopium.4 
 
Figure 1: Structure of α-Cyclopiazonic Acid 1. 
Hozapfel determined its structure through a series of chemical degradations and found 
two structurally related metabolites α-cyclopiazonic acid imine 2 and β-cyclopiazonic 
acid 3.5  
 
Figure 2: Structure of α-Cyclopiazonic Acid Imine 2 and β-Cyclopiazonic Acid 3. 
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1.2	  Biosynthesis	  
Biosynthetic studies of α-CPA 1 commenced with the postulate that α-CPA 1 was 
derived from either a molecule of tryptophan and two C5-units from mevalonic acid or 
from a molecule of tryptophan, a C5 unit from mevalonic acid and two molecules of 
acetic acid.6 The latter possibility would be analogous to the biosynthesis of 
tenuazonic acid 4, which is biosynthetically derived from L-isoleucine 5 and 2 
molecules of acetic acid 6. Displayed in Scheme 1. 
 
Scheme 1: Biosynthesis of Tenuazonic Acid. 
With this idea in hand, Penicllium cyclopium Westling was grown on a shake culture 
and radioactive labelled [1-14C] sodium acetate, [2-14C] mevalonic acid and DL-
tryptophan, universally 14C-labelled in the phenyl ring, was added to separate 
mediums. 24.7% of the labelled tryptophan was incorporated into the α-CPA 1 
isolated; this efficient inclusion was considered as sufficient evidence to deem 
tryptophan as a precursor to α-CPA 1. The [1-14C] sodium acetate derived α-CPA 1 
and [2-14C] mevalonic acid derived α-CPA 1 was degraded by chemical methods. 
This is depicted in Scheme 2.  
 
Treatment of 1 with 0.1N H2SO4:MeOH (1:1) at reflux for 22 hours induced a retro-
Claisen condensation producing one mole of acetic acid and desacetylcyclopiazonic 
acid 7. The acetic acid was in part degraded by the Schimdt procedure to give carbon 
dioxide collected as its barium carbonate and the remaining acetic acid was converted 
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into the p-bromophenacyl ester. The acetic acid obtained from the [2-14C] mevalonate 
derived α-CPA 1 was inactive whilst the [1-14C] acetate labelled α-CPA 1 accounted 
for 35% of the activity of the starting material. This observation indicates C-17 and C-
18 are derived from acetic acid. 
 
Scheme 2: Chemical Degradation of α-Cyclopiazonic Acid 1. 
The hydrolysis of tenuazonic acid 4 gives 3-amino-4-methylhexan-2-one 5, acetic 
acid 6 and carbon dioxide. These results lead to the expectation that the hydrolysis of 
8 synthesised by treating crude 7 with diazomethane would give exclusively 9. 
However presence of the methyl enol ether allowed two mechanistic pathways to 
occur: one resulting in the formation of the expected amino-ketone through hydrolysis 
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of the amide, decarboxylation and subsequent hydrolysis of the enol ether to the 
methyl ketone creating 9, one equivalent of methanol and carbon dioxide, the second 
by a retro-Claisen condensation generating a N-acetylamino acid which is further 
hydrolysed to 10 and acetic acid representing C-7 and C-8. Treatment of 10 with 
thionyl chloride in methanol gave 11. The acetic acid was partly converted to p-
bromophenylacyl ester and was degraded by the Schmidt procedure and collected as 
its barium carbonate. The [2-14C] mevalonate derived α-CPA 1 was inactive whilst 
the [1-14C] acetate labelled α-CPA 1 accounted for 33% of the activity of the starting 
material. This observation indicates C-7 and C-8 are derived from acetic acid.  
 
The Kuhn-Roth oxidation with chromium(VI)oxide of 8 yielded acetic acid which 
was degraded by identical methods. This time the acetic acid obtained form the [2-
14C] mevalonate derived α-CPA 1 accounted for 48% of the activity of the [2-14C] 
mevalonate labelled α-CPA 1 whilst the [1-14C] acetate labelled α-CPA 1 accounted 
for 15% of the specific molar activity of the starting material. Therefore C-10 and the 
geminal dimethyl group are biosynthetically derived from mevalonic acid. This is 
summarised in Scheme 3. 
 
Scheme 3: Summary of the Biosynthesis α-Cyclopiazonic Acid 1. 
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During the investigations it was found that initially β-cyclopiazonic acid 3 
concentration rapidly increases when α−CPA 1 is traceable, when formation of 1 
increases concentration of 3 falls rapidly. This observation implies that 
β−cyclopiazonic acid 3 is the direct biological precursor to α−CPA 1. Culturing 
labelled β-CPA 3 and adding this to the shake culture tested this proposal. On 
isolation of α−CPA 1 it contained 67% of the added label and 18% remained in 
solution. This result verifies that 3 is a direct precursor of 1. 
  
The stereochemistry of the enzymatic oxidative cyclization of β−CPA 3 to α−CPA 1 
was investigated by introduction of (3R) and (3S)-[3-3H, 3-14C] tryptophan into 
cultures of Penicillium cyclopium Westling.7 The tritium from (3R)-[3-3H] tryptophan 
was retained during conversion into α−CPA 1, conversely (3S)-[3-3H] tryptophan lost 
all of its tritium. As expected the racemic [3-3H] tryptophan lost half of its tritium. All 
of the tritiated trytophans were incorporated into β−CPA 3 confirming the integrity of 
the methylene group during the preceding steps. These observations show that the 
pro-S-tritium is lost during the final cyclisation indicating that the C-C bond is formed 
on the opposite side of the molecule to the proton removed.8 This is represented in 
Scheme 4. 
 
Scheme 4: Stereochemistry of Enzymatic Oxidative Cyclisation of β−CPA 3. 
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The stereochemical aspects of the formation of ring D have been investigated by 
adding stereospecifically labelled [4-3H] mevalonic acid lactone, (3RS)-[2-14C] and 
(3R)-[3-14C] mevalonic acid lactone to cultures of Penicillium cyclopium Westling. 
Analysis signified the incorporation of the (3R)-[3-14C] mevalonic acid lactone with 
retention of 4-pro-R-hydrogen. Spectroscopic equivalence of the geminal methyl 
group in 1 makes unambiguous assignment impossible. However conversion of α-
CPA 1 to O-methyldesacetylcyclopiazonic acid 8 allowed for absolute assignment of 
the dimethyl geminal group, it was found that the Z-methyl becomes the methyl group 
at C-22.9 This depicted in Scheme 5. 
 
Scheme 5: Stereochemistry of Dimethyl Geminal Moiety.  
A quintet of iso-enzymes called β-cyclopiazonate oxidocyclases is responsible for the 
cyclisation of β−CPA 3 to α−CPA 1.10 The mechanism of the oxidative cyclisation of 
β−CPA 3 to α−CPA 1 has been extensively investigated by a series of kinetic studies 
implementing electron acceptors and carriers and has been described as the so-called 
‘ping-pong’ mechanism.11 This is delineated below in Scheme 6. 
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Scheme 6: Mechanism of Enzymatic Oxidative Cyclisation. 
The mechanism above is however fundamentally incorrect and it would be realistic to 
relate the 1st step of the oxidative cyclisation to the oxidation of dihydropyridine with 
dichlorodicyanoquinone. This implies that an imidazole residue is removing the 
indolic proton and the pro-S hydrogen being accepted by the electron acceptor. 
 
Recently α−CPA 1 has enjoyed a heightened profile since it was discovered that it is 
a specific inhibitor of Ca2+ATPase, the very origin of its toxicity.12 Ca2+ATPase is a 
P-type ATPase, which constitutes of a superfamily of cation transport enzymes, 
present both in prokaryota and eukaryota, whose members mediate membrane flux of 
all common biologically relevant cations.13 Since α−CPA 1 is a specific inhibitor of 
the Ca2+ATPase it is regarded as useful biological standard. 
1.3	  Previous	  Syntheses	  
To date there have been three total synthesises of α−CPA 1, all starting from a 
suitable 3,4 disubstituted indole. Kozikowski and Greco accomplished the first 
synthesis in 1984.14 They took the readily available N-tosyl derivative of indole-4-
carboxyaldehyde 18 and transformed it to 19 in 89% yield using a Wittig reaction 
followed by palladium catalysed hydrogenation. The ketone moiety of 4-(1-tosyl-1H-
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indol-4-yl)butan-2-one 19  was protected as its ethylene ketal using ethane-1,2-diol 
under acidic conditions and subsequent deprotection of the N-tosyl group gave 20 in 
92% yield. Under standard Vilsmeier protocol position 2 of the indole was formylated 
providing 21, followed by the use of 2-acetamido-3-methoxy-3-oxopropanoic acid, 
the amidoacrylate group was efficiently installed and subsequent protection of the 
indolic nitrogen with methyl chloroformate gave 22 in overall yield of 46% from 20. 
Deprotection of the ketal followed by formation of the thermodynamic silyl enol ether 
and reaction with phenylsulphenyl chloride afforded 23 in 54% yield. Intramolecular 
Michael addition promoted by DBU formed the central carbocyclic ring of 24 in 55% 
yield. On conversion of 24 to 25 an interesting Raney Nickel induced desulfurization 
occurs leading almost exclusively to the cis compound 25 in 72% yield. This reaction 
is contrathermodynamic in nature since stirring of 25 with DBU leads exclusively to 
the trans isomer. Closure of ring D was affected by use of thiophenol with 
magnesium(II)triflate, creating α-phenylthioamide intermediate 26 in 80% yield. A 
survey of a multitude of organometallic reagents found that dimethylzinc in 
chloroform was the sole reagent capable of replacing the thio group and installing the 
geminal dimethyl moiety, converting 26 to 27 in 73% yield. Deprotection of the 
acetamide 27 with triethyloxonium tetrafluoroborate in dichloromethane occurred in 
79% yield followed by reaction with diketene afforded acetoacetamide 28 in 80%. 
Base catalysed cyclisation of 28 to the tetramic acid residue with sodium methoxide 
surprisingly gave iso α-CPA 29. Epimerization with triethylamine in chloroform gave 
α-CPA 1:iso α-CPA 29, 5:2.  
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Kozikowski and Greco completed the first synthesis of α-CPA 1 in 16 steps from 1-
tosyl-1H-indole-4- carbaldehyde 18 in an overall yield of 2.1 %. This is shown below 
in Scheme 7. 
  
Scheme 7: Kozikowski and Greco’s Synthesis of α-CPA 1. 
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Muratake and Natsume completed the second synthesis in 1985.15 This is outlined in 
Scheme 8. 
 
 
Scheme 8: Muratake and Natsume’s Synthesis of α-CPA 1. 
In an almost identical initial sequence compound 30 was protected as its ethylene 
ketal, the methyl formate group was removed with potassium hydroxide in a water, 
methanol and dimethoxyethane to permit the subsequent Vilsmeier reaction. The tosyl 
group was then reinstalled giving 31 in 66% over 4 steps. Deprotonation of ethyl 
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isocyanoacetate with potassium tert-butoxide gave oxazolidine derivative 32, a 
second deprotonation cleaved the oxazolidine forming 33 in 68% yield. This is an 
interesting alternative to forming the amidoacrylate moiety of 33 compared with the 
first synthesis. Protection of the nitrogen functionality with chloro(methoxy)methane 
in THF followed by removal of the ethylene ketal generated 34 in 84% yield. An 
intramolecular Michael reaction, initiated by treatment with DBU was utilised to 
close the central ring forming 35 in 52% yield. In one synthetic operation both the 
methoxy methyl group and the aminal were hydrolysed, followed by closure of ring D 
to afford ketimine derivative 36 in 66%. Fortunately epimerization at C-8 occurred 
during this step. Installation of the geminal dimethyl group was achieved by initially 
complexing ketimine derivative with BF3.OEt2 followed by addition of methyl 
lithium, subsequent deprotection of the indolic nitrogen yielded 37 in 20% yield. The 
tetramic acid residue was installed using the method of Kozikowski and Greco;14 
addition of the pyrolidine to diketene followed by a Diekman condensation furnished 
iso α-CPA 29 followed by isomerisation yielded α-CPA 1 in an overall yield of 1.6% 
over 13 steps.  
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Scheme 9: Knight and Haskins’ Synthesis of α-CPA 1 
Knight and Haskins completed the third and final synthesis of α-CPA 1 featuring a 
novel intramolecular cationic cascade.16 As with all previous synthesises a C-4 
substituted indole derivative was the starting point. In this case indole-4-methanol 38 
was protected at oxygen with complete chemoselectivity using tert-
butylchlorodiphenylsilane with imidazole in THF. Formylation under standard 
Vilsmeier conditions formed 39 in 78% yield. Indolic protection with tosyl chloride 
followed by homologation under Wadsworths-Emmons conditions gave 
α,β unsaturated ethyl ester 40. Addition of (2-methylprop-1-enyl)magnesium bromide 
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in the presence of phenylthiocopper gave exclusively the 1,4 adduct in 53% yield. 
Deprotonation with LiHMDS and subsequent addition of trisyl azide gave 41 in 62% 
yield. Reduction of azide 41 with triphenylphosphine and water in THF followed by 
nosylation gave cationic cascade precursor 42 in 43% over two steps. Treatment of 42 
with triflic acid in chloroform at room temperature yielded tetracycle 43 in 74% yield, 
impressive for such an elaborate step. Global deprotection with thioglycolate 
proceeded in 82% yield giving common intermediate 44. The synthesis was 
completed with the addition of diketene in methylene dichloride yielding 89% of 1. 
Summarised in Scheme 9. 
 
Aggarwal and Co-workers have recently published a fourth approach to α-CPA 1. 17 
Contrasting all previous syntheses the tetramic acid moiety of 1 was simplified to 
isoxazole 45. This disconnection is based on literature precedent for the 
hydrogenolysis of isoxazoles.18 19, 20, 21, A biomimetic approach has for the 
installation of the two non-indolic rings has been proposed based on the ‘ping-pong’ 
mechanism.11 Two complimentary routes to aziridine 46, based on previous work 
from the Aggarwal group,22, 23 have been considered via either indolic imine 47 and 
isoxazole sulfonium ylide 48 or iminic isoxazole 49 and indolic sulfonium ylide 50. 
This is summarised in Scheme 10. 
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Scheme 10: Aggarwal’s Retrosynthetic Analysis of α-CPA 1 
At the present time the synthesis of isoxazole partners 48 and 50 has been achieved. 
After intense investigation the synthetic sequence displayed below in Scheme 11 was 
found to be the optimal route to such species. 
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Scheme 11: Synthesis of Isoxazole Partner 
Implementing a modified procedure to the approach published by Gelin and co-
workers,24 alcohol 53 was synthesised by addition of chloro acetyl chloride in 
acetonitrile to a complex of ethyl aceto acetate 51 and magnesium(II)ethoxide in 
benzene. Treatment of crude 52 with hydroxylamine hydrochloride and sodium 
acetate in ethanol furnished 53 in 79% yield from ethyl aceto acetate 51. Bromide 54 
was obtained in quantative yield by treatment of alcohol 53 with an equimolar amount 
of phosphorus tribromide  and DMF in refluxing toluene. The best possible conditions 
for the displacement was the treatment of bromide 54 with tertahydrothiophene and 
sodium perchlorate in acetone for two days at room temperature affording salt 55 in 
91% yield. The oxidation of alcohol 53 was accomplished by stirring 53 in 
dichloromethane with PCC for two weeks yielding 82% of aldehyde 56. 
Tosylhydrazone 57 was readily available in 76% yield by reaction of tosylhydrazide 
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with aldehyde 56. Attempts to isolate 58 were unsuccessful, freshly prepared sodium 
methoxide affected the deprotonation of 57 however upon even low temperature 
work-up decomposition to the diazo compound occurred. This observation is not 
problematic since the catalytic aziridination can occur direct form the diazo 
compound or via in situ deprotonation. Aggarwal and co-workers plan to obviously 
synthesise the indole partner and finish the synthesis. 
1.4	  Retrosynthetic	  Analysis	  
On inspection it was conceived that α-CPA 1 could be synthesised from a radical 
cascade process. Similarly to all previous total syntheses of α-CPA 1 the teramic acid 
moiety will be installed in an identical fashion. Retrosynthetic analysis revealed that 
the ABC ring system of simplified species 59 could be closed in one step from acyclic 
intermediate 60. Tin mediated homolytic cleavage of the carbon-bromine bond 
forming an aryl radical, followed by a tandem 5-exo-trig, 6-endo-trig cascade 
sequence would provide a suitable intermediate that when treated with acid would 
close ring D via a stable tertiary cation and furnish the tetracyclic core of α-CPA 1. 
The triene moiety of 60 could be simplified to silyl protected derivative 61. Two 
different approaches were envisaged for the synthesis of the amino acid side chain of 
61. In disconnection b: it is postulated that an olefin cross metathesis route could yield 
61; protected allyl amine 62 with vinyl glycine derivative 63 with the aid of a suitable 
Grubbs alkene metathesis catalyst would yield 61. Alternatively an enantiopure vinyl 
aziridine 65 could be opened 1,4 by diene 64.   
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Scheme 12: Retrosynthesis of α-CPA 1. 
The synthesis of the 1,2,3 trisubstituted aniline 62 has been previously described by 
Parsons et al. in their synthesis of lysergic acid and derivatives.25, 26, 27 These papers 
also describe 5-exo-trig, 6-endo-trig radical cascades. 
1.5	  Radical	  Cascades	  in	  Natural	  Product	  Synthesis	  
The structural framework of lysergic acid was synthesised from acyclic intermediate 
66 by slow addition of a solution of tributyltin hydride and AIBN in toluene to a 
boiling solution of eneamine 66. Two tetracyclic products were formed 67 and 68 in 
73% yield and in a ratio of 1:2. After the initial previously unprecedented 5-exo-trig, 
6-endo-trig bicyclisation, two competing modes of cyclisation were possible, the 
major product 68 from the 6-endo-trig mode and minor 67 from the 5-exo-trig mode. 
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Heating precursor 66 for 5 hours in toluene to cause closure of ring D circumvented 
this problem then addition of AIBN and Bu3SnH formed 68 exclusively in 74% yield. 
 
Scheme 13: Parsons et al. Synthesis of Lysergic Acid Derivatives. 
Since the discovery of the stable triphenylmethyl radical by Gomberg in 1900,28, 29, 30, 
the ability of the organic chemist to manipulate the reactivity of radicals has increased 
to such an extent that controlled chain reactions, aided by the development of a 
diversity of new reagents and synthetic methods, have been implemented to construct 
complex molecular architectures in one step from acyclic precursors, this being 
exemplified by the ubiquity of publications in the literature. The forthcoming pages 
are merely a representation of the possibilities of radical cascade reactions.   
 
Bowman et al. have demonstrated that imines are efficient radical acceptors in their 
synthesis of a variety of nitrogen heterocycles.31  An example is Monomorine 73, 
where acyclic phenyl selenide precursor 70 was subjected to tributyltin hydride in 
toluene with a catalytic amount of AIBN. A reactive primary radical was formed 
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which cyclised in a 6-endo-trig fashion creating high energy nitrogen based radical 
species 72 that spontaneously cyclised in a 5-exo-trig mode to form monomorine 73. 
 
Scheme 14: Synthesis of Monomorine 73. 
Senboku et al demonstrated use of a differing radical cascade sequence towards 
indolizidines.32 In one pot allyl amine derivative 74 was exclusively N-chlorinated on 
treatment with N-chlorosuccinimide in toluene for thirty minutes, subsequent addition 
of AIBN and TBTH formed a highly reactive nitrogen bound radical species 75 which 
cyclised in a 5-exo-trig fashion onto the styrene moiety forming benzylic radical 76 
that reacted in 5-exo-trig mode to close the indolizidine ring structure. Compounds 77 
and 78 were formed in 82% yield in a ratio of 3:5.  
 
Scheme 15: Radical Approach to Indolizidines.  
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Readily available 2-(bromomethyl) aziridine derivatives were employed in a 
fragementation, 5-exo-trig, 5-exo-trig sequence to yield indolizidine structures by De 
Kimpe and Co-Workers.33 
 
Scheme 16: Alternative Radical Approach to Indolizidines. 
Pattenden and Wiedenau have demonstrated the use of cyclopropanes in radical 
cascades towards the cortical steroid architecture.34 Iodide 83 was treated 
(tristrimethylsilyl)silane and AIBN in benzene affording 86 in 16% yield.  
 
Scheme 17: Radical Approach to the Cortical Steroid Architecture 
Bowman et al. have publicized that cyanide groups are also radical acceptors.35 On 
exposure of 87 to tributyltinhydride and a catalytic amount of AIBN, aryl radical 88 
was formed; this reacted in a 5-exo-trig mode onto the nitrile group creating iminyl 
radical, 89, that cyclised in an identical manner onto the allyl group forming a 
reactive primary radical. Subsequent formation of aziridine 92 followed by 
fragmentation gave 93 in 34% yield. 
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Scheme 18: Cyanide as a Radical Acceptor. 
An elegant utilization of a silicon tether in combination with a domino intra-
intermolecular cascade sequence yielding 5,5 fused ring systems in moderate yields.36 
This is displayed below in Scheme 19. 
 
Scheme 19: A Domino Intra-Intermolecular Cascade 
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Rawal and co-workers exploited the strained nature of epoxides and reactivity of 
alkoxy radicals in their epoxide fragmentation, H-abstraction, 5-exo-trig cyclisation 
sequence that transformed 100 to 104.37  
 
Scheme 20: Epoxides and Alkoxy Radicals 
Titanocene medicated reductive epoxide opening has been utilised in a remarkable 6-
endo-trig, 6-exo-dig tandem sequence towards the synthesis of Smenospondiol. A key 
requirement for this process was the use of a mixture of benzene and THF (5:1) at 
reflux.38 39,  This is displayed in Scheme 21. 
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Scheme 21: Titanocene as a Radical Initiator. 
Samarium(II)iodide has been employed as a selective and mild reductant in many 
radical and anionic cascades. Kilburn et al. have utilised this reagent in a synthesis of 
paconilactone B; their route features a cascade sequence involving a methylene 
cyclopropane group.40 Treatment of ketone 110 with samarium diiodide in the 
presence of HMPA and tBuOH results in single electron reduction of 110 to give ketyl 
radical 111 that spontaneously cyclises in a 5-exo-trig fashion to give an unstable 
cycopropyl carbinyl radical that undergoes facile ring expansion to give homoallyl 
radical 112, subsequent 5-exo-dig cyclisation furnishes 113 in 63% yield as 10:1 
mixture of diastereoisomers at the hydroxyl substituted carbon. 
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Scheme 22: Samarium(II)Iodide Initiated Cascade. 
The use of indium(I)iodide to generate radicals has been reported by Ranu and 
Mandal.41 Although yet to be utilized in a domino reaction their observation is worthy 
of note. It was found that sonication of intermediate 114 at room temperature was the 
only method of inducing cyclisation to 117. Reflux created a complex mixture and no 
reaction occurred at room temperature. Acetonitrile as a solvent was deemed essential 
as no reaction occurred in less polar solvents. The addition of radical quenchers such 
as TEMPO and p-benzoquinone arrested the cyclisation process. One downfall of the 
process was that an aryl group and an electron withdrawing group had to be adjacent 
to the latent radical. The mechanism is summarised below. 
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Scheme 23: Indium(I)Iodide as a Radical Initiator. 
An enantioselective cascade has been utilised by Miyabe et al. for the synthesis of 
highly functionalised cyclic amides.42 After intense investigation it was found that the 
optimal conditions were the use of zinc(II)triflate as a Lewis acid, which was essential 
since the reaction ceased without it, oxazole as a chiral ligand and initiation with 
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triethylborane. Once 118 is held in the fixed transition state 119 by a chiral Lewis 
acid, attack of the isopropenyl radical proceeds stereospecifically, and is followed by 
halogen abstraction to yield 120 in 75% yield, 82% ee. This is a remarkable 
transformation forming 3 bonds, a quaternary centre and two stereogenic centres 
through an inter-intra-inter molecular cascade. 
 
Scheme 24: An Inter-Intra Enantioselective Cascade. 
Gonzalez and Molina-Navarro described the use of an intramolecular Minisci-type 
reaction in an approach to Spongidines.43 Under acidic conditions, 121 exists in 
solution with a significant concentration of its enol tautomer. Manganese(III)acetate 
abstracts an electron from oxygen, to form alkoxy radical cation 122. A triple radical 
cyclisation ensues in 6-endo-trig, 6-endo-trig, 6-exo-trig fashion, followed by 
rearomatisation yielding 123 in 40% yield. 
 
Scheme 25: Manganese(III)Acetate as a Radical Initiator. 
The scope and diversity of radical cascades has been demonstrated. Halides, selenyl 
derivatives, xanthates, carbonyl groups and epoxides can all be used as latent radicals. 
Apart from the widely used tributyltinhydride and AIBN system other radial initiators 
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such as tris(trimethylsilyl)silane, TiCp2Cl2, triethylborane, indium iodide, 
samarium(II)iodide and manganese(III)acetate have all been successfully employed. 
A broad range of functional groups including alkenes, alkynes, imines, nitriles, 
aziridines, epoxides, aromatic heterocylces and cyclopropanes all accept radicals, 
many reacting further in cascade or domino sequences. 
 
Tandem radical reactions exemplify the elegance of organic synthesis in the 21st 
century, from the initial stages of designing a synthetic sequence, through theory and 
imagination, to the execution in a laboratory. 
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Retrosynthetic analysis of α−CPA 1 has led to two strategies for the construction of 
the amino side chain either: a cross metathesis between allyl amine 1.62 and protected 
vinyl glycine 1.63 or a nucleophilic 1,4 addition of diene 1.64 onto vinyl aziridine 
derivative 1.65.   
 
Scheme 26: Key Intermediates of Retrosynthetic Analysis 
On reviewing the literature the initial plan was to implement the cross metathesis 
route first since vinyl glycine derivatives have been previously used as partners in 
cross metathesis, 44 45, 46, 47, and the synthesis of enantiopure vinyl glycine has been 
published. 48  
 
1,2,3-trisubstituted aromatic compounds are not trivial molecules to synthesise. The 
aromatic precursor 1.62 has formerly been synthesised by Parsons et al. in their 
synthesis of lysergic acid,25, 26 however it requires the use of the toxic mercuric 
acetate so an alternative strategy was investigated. Pearson et al. have described 
hydrogen bonding induced regioselective bromination of phenols.49 Premixing 
bromine with tert-butyl amine in toluene at -70oC, followed by slow addition of 
phenol, gave exclusively 2-bromophenol in 60% yield. This method has been applied 
to 2-methoxyphenol obtaining 2-bromo-6-methoxyphenol in 87% yield.50 51 The plan 
was to extend this idea to aniline derivative 2.01, in the hope that chelation through a 
double hydrogen bonded intermediate 2.02, followed by electrophilic aromatic 
substitution would give compound 2.03. 
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Scheme 27: Proposed Hydrogen-Bonded Transition State  
Unfortunately all attempts to induce a regioselective bromination were futile under 
the reported conditions; TLC analysis showed multispot mixtures so the previous 
method of synthesing 2.03 was employed. 
2.1	  Synthesis	  of	  Aromatic	  Cross	  Metathesis	  Partner	  
3-Nitrophthalic acid 2.04 was converted exclusively to 2-bromo-3-nitrobenzoic acid 
2.06 in 74% yield via the organomercury compound 2.05 following the procedure of 
Culhane and co-workers.52  Reduction of carboxylic acid 2.06 with two equivalents of 
borane:THF complex in THF at 0oC gave the desired benzyl alcohol 2.07 in 91% 
yield. Reduction of the nitro moiety in 2.07 to aniline derivative 2.03 was initially 
tried with tin(II)chloride in ethanol, 53  however this proved to be unsuccessful. The 
use of iron powder in refluxing acetic acid and ethanol efficiently converted 2.07 to 
aniline 2.03 in 75% yield. Protection of the alcohol functionality of 2.03 with tert-
butyl dimethylsilyl chloride with dimethylformamide as a solvent, due to solubility 
issues, occurred in a satisfactory 92% yield furnishing silyl ether 2.08. Deprotonation 
with freshly formed LDA in THF followed by addition of allyl bromide gave allyl 
amine 2.09 in 72% yield, the N N-diallyl species was isolated in 7% yield along with 
a mixed fraction of 10%. Subsequent amine protection with acetyl chloride gave 
acetamide 2.10 in 90% yield. It was found that if compound 2.09 was taken on crude 
and protected as its acetamide, then 2.08 could be converted directly to 2.10 in an 
increased yield of 80%, due to easier separation of the diallyl impurity. The N-Boc 
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analogue 2.11 was synthesised using identical methods from 2.08 in 88% yield. Thus 
three suitably functionalised allyl aniline derivative had been synthesised to test the 
proposed cross metathesis strategy.  
 
Scheme 28: Synthesis of Substituted Allyl Anilines. 
2.2	  Synthesis	  of	  Amino	  Acid	  Cross	  Metathesis	  Partner	  
Synthesis of the amino acid cross metathesis partner was subsequently investigated. A 
paper published by Rapaport et al. describes the synthesis of L-vinylglycine.48 Initial 
studies following this route showed it needed refining. Starting with D-methionine 
2.12, the carboxylic acid group was protected as its methyl ester using a protocol 
published by Rachele.54 Recrystallisation of 2.13 was problematic following 
Rachele’s method and it was found that the most effective procedure was dropwise 
addition of a highly concentrated methanolic solution of 2.13 via a dropping funnel to 
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a stirring flask of ether. The hydrochloride salt 2.13 was dissolved in a 1:1 mixture of 
sodium hydrogen carbonate solution and ethyl acetate followed by dropwise addition 
of benzyl chloroformate yielding protected amine 2.14. Oxidation of sulphide 2.14 to 
sulphoxide 2.15 was achieved using sodium metaperiodate in aqueous methanol. In 
the paper they report the distillation of 2.15; however, this was not satisfactory 
producing a multicomponent mixture. It was found that passing the compound 
through a plug of silica and eluting with MeOH:CH2Cl2, 5:95 was the preferred 
method of purification. Heating pure 2.15 in a Kugelhohr distillation apparatus at 
150oC at 3mmHg yielded 56% of 2.16 after column chromatography. With both 
partners in hand, attention turned towards the cross metathesis. 
 
Scheme 29: Synthesis of Vinylglycine 
2.3	  Cross	  Metathesis	  in	  Synthesis	  
Since its discovery olefin metathesis has been ubiquitous in the literature.55 
Historically it has been studied from a mechanistic standpoint56 and from the 
perspective of ring opening polymerisation (ROMP).57, 58 Until the development of 
the 1st generation of commercially available catalysts such as the ruthenium 
benzylidene 2.17 by Grubbs et al.59, 60,  and the molybdenum alkylidene 2.18 by 
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Schrock et al.61 62, 63, which can tolerate reasonably well the diverse functionality 
encountered in organic synthesis, olefin metathesis in natural product synthesis was 
very rare. Since their introduction the realisation of alkene metathesis as an effective 
tool in organic synthesis began with the ring closing metathesis (RCM) of acyclic 
dienes for the construction of complex carbocycles and heterocycles.64  
 
Scheme 30: First Generation Olefin-Metathesis Catalysts. 
The quantity of papers concerning RCM and ROMP vastly outweighed the number 
reporting successful cross metatheses (CM), however the development a second 
generation of active and robust ruthenium catalysts 2.19 to 2.24 which combine the 
activity previously only associated with Schrock’s molybdenum catalyst 96 with an 
impressive functional group tolerance has caused a surge of interest in CM as 
powerful synthetic tool. 65 66,  
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Scheme 31: 2nd Generation Ruthenium Alkene-Metathesis Catalysts. 
Previous work by Parsons et al. involving cross metathesis synthesising substituted 
nitro alkenes used Grubbs second-generation catalyst 2.2067 and previous work 
involving vinyl glycine derivatives also used 2.20.44, 45, 46, 47 Therefore 2.20 was 
initially used 
Grubbs and co-workers have published a useful report categorizing terminal alkenes 
into 4 differing classes in terms of their participation in cross metathesis: Type 1: 
rapid homodimerisation, homodimer participates in a subsequent metathesis reaction, 
Type 2: slow homodimerisation, homodimer sparingly participates in a subsequent 
metathesis reaction, Type 3: no homodimerisation, Type 4: olefin inert to CM and 
does not deactivate the catalyst (spectator).68  
2.4	  Homodimerisation	  of	  Vinylglycine	  
On this basis vinylglycine derivative 2.16 would described as Type 1 with respect to 
Grubbs second generation catalyst 2.20, since treatment of 2.16 with 10mol% of 2.20 
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gave the homodimersation product 2.25 and it has been demonstrated that 
vinylglycine derivatives have been utilised in CM. 44, 45, 46, 47 
HN O
O
Ph
O
O NH
HN O
O
Ph
O
O
Ph
O
O
O
O
Reagents and Conditions: 2.20 (10mol%), CH2Cl2, 18hr, 74%  
Scheme 32: Synthesis of Homodimer 2.25 
2.5	  X-­‐Ray	  Crystal	  Structure	  of	  2.25	  
The structure of 2.25 has been confirmed by X-ray crystallography (Figure 3) 
 
Figure 3: ORTEP Drawing of Vinyl Glycine Dimer 2.25. 
The compound 2.25 is a chiral molecule belonging to a monoclinic crystal system 
with a C2 (No.5) space group. The dimer has potential use as a chiral auxillary. 
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2.6	  Cross	  Metathesis	  of	  Vinyl	  Glycine	  and	  Allyl	  Amide	  Analogues	  
Initially allyl amine substrate 2.09 was tested; unfortunately this gave an inseparable 
mixture due to similar polarity of starting materials and product. Acetamide 2.10 gave 
62% of 2.26 after treatment with 10mol% Grubbs II 2.20, whilst carbamate 2.11 gave 
56% of 2.27. A publication by Fukuyama et al. on a total synthesis of kainic acid 
utilises a RCM metathesis of an allylcarbamate,69 it was found that Grubbs-Hoyveda 
II catalyst 2.22 at an elevated temperature in DCE needed very low catalyst loadings. 
This was tested on our system, with 2.10 and 2.11, and gave a multispot component 
mixture, possibly attributed to the higher temperature leading to an isomerisation of 
the double bond into conjugation. The outcomes are summarised in table 1. 
OTBS
Br
N
R
Br
N
R
HN OBn
O
O
O
TBSO N
H
CO2Me
CO2Bn
2.09 R=H
2.10 R=Ac
2.11 R=Boc
2.16 2.26 R=Ac
2.27 R=Boc
Reagents and Conditions: 1) See Table 1
1.
 
Scheme 33: Cross-Metathesis of Vinyl Glycine  
R Catalyst Loading/% Solvent Temp/oC Time/hr  Yield/% 
H 2.20 10 DCM 40 18 Inseparable 
Ac 2.20 10 DCM 40 18 62 
Ac 2.22 5 DCE 80 18 Decomposition 
Boc 2.20 10 DCM 40 18 54 
Boc 2.22 5 DCE 80 18 Decomposition 
Table	  1:	  Results	  of	  Cross	  Metathesis	  of	  Allyl	  Amide	  Analogues.	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2.7	  Elaboration	  of	  2.26	  
With the allyl amino acid side chain installed our attention turned towards elaboration 
of the silyl ether. Depotection of 2.26 with hydrofluoric acid in acetonitrile gave 90% 
of benzyl alcohol 2.28. Attempts at oxidation of the benzylic position with 
manganese(IV)oxide in both THF and methylene dichloride gave multispot 
component mixtures possibly due the formation of a nitrogen based radical cation. 
Ba(KMnO4) gave a similar result. 
 
Scheme 34: Elaboration of Cross-Metathesis Product 
2.8	  Retrosynthesis	  part	  II	  	  
Concurrent experiments indicated that a different retrosynthetic plan should be 
implemented. Deprotection of 2.10 with hydrofluoric acid in acetonitrile, followed by 
oxidation with manganese(IV)oxide in tetrahydrofuran yielded benzaldehyde 2.31 in 
78% yield from silyl ether 2.10. Phosphonate 2.33 for the Horner-Wadsworth-
Emmons reaction was prepared using a method published by Yokomatsu et al. 
utilising an iodide catalysed Arbuzov reaction.70  
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Scheme 35: Preparation of Horner-Wadsworth-Emmons reaction precursors. 
Following a procedure published by West and Wang in their synthesis of (E)-1,3-
dienes,71 deprotonation of phosphonate 2.33 with butyllithium in THF at -78oC 
followed by addition via canular of aldehyde 2.31 in HMPA at -78oC gave, by TLC 
analysis, complete consumption of starting material 2.31 and the appearance of a 
single less polar product. Isolation by column chromatography yielded only 20% by 
mass of the isolated product, which rapidly decomposed on standing in the freezer 
meaning characterisation was impossible. This observation and the apparent difficulty 
in oxidising 2.28, led us to back to the blackboard. 
 
Scheme 36: Attempted Synthesis of Triene Model 
It was conceived that a synthon of the proposed vinyl aziridine 1.65 could be prepared 
by a cross metathesis of allyl bromide, type 1 under Grubbs classification,68 with 
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vinyl glycine 2.16. The Horner-Wadworth-Emmons reaction would be utilised prior 
to instalment of allyl amine side chain. 
 
 
Scheme 37: 2nd Generation Retrosynthesis of α-CPA 1. 
2.9	  Synthesis	  of	  Diene	  2.41	  
The construction of intermediate 2.41 was a relatively trivial process. Protection of 
aniline 2.08 as its acetamide followed by deprotection of the silyl ether 2.38, and 
subsequent oxidation of benzyl alcohol 2.39 furnished benzaldehyde derivative 2.40 
in 76% yield from 2.08. Following the protocol of West and Wang,70 aldehyde 2.40 
was converted to 1,3 diene 2.41 in 79% yield. 
 
Scheme 38: Synthesis of Diene 2.41 
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2.10	  Synthesis	  of	  2.36	  
The valuable intermediate 2.36 was synthesised from vinylglycine 2.16 in 85% yield 
using 10 equivalents of allyl bromide in the presence of 10mol% of Grubbs second 
generation catalyst 2.20. 
  
Scheme 39: Cross Metathesis of Allyl Bromide with Vinyl Glycine. 
2.11	  Nucleophilic	  Substitution	  Route	  
Originally a similar strategy for the installation of the allyl group onto 2.08 was 
implemented. Treatment of 2.41 with one equivalent of LDA at -78oC, followed by 
dropwise addition of 2.36 in THF via canula at -78oC, resulted in the isolation of just 
the two starting materials. It is known that Finkelstein conditions can assist 
nucleophilic displacement of bromides.72 Premixing of bromide 2.36 with one 
equivalent potassium iodide for one hour in THF, followed by dropwise addition to 
the lithiate of 2.41 at -78oC in THF was also a futile process, with no conversion to 
the desired product 1.60. It was perceived that possibly a π-allyl palladium approach 
could solve our dilemma.  
2.12	  Palladium	  in	  Synthesis	  
The majority of fundamental processes catalysed by palladium were well established 
by the mid-1980’s; however their use and acceptance as synthetic procedures was 
minimal until the mid-1990’s, whereas today palladium is one the most useful metals 
in a chemist’s armoury. A beautiful combination of palladium catalysed processes is 
demonstrated towards the synthesis of (+)-δ-lycorane.73  
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Scheme 40: Palladium in the Synthesis of (+)-δ-Lycorane. 
2.13 π-­‐Allyl	  Palladium	  Catalysed	  Aminations	  
On inspection of the literature for guidance in palladium catalysed allylic aminations, 
several sets of conditions all with allyl acetates were found:  
 
Scheme 41: Pd2dba2 with dppb.74 
 
Scheme 42: Pd(DIPHOS)2 in THF.75 
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Scheme 43: [Pd(η3-C3H5)Cl]2 with BINAP. 76 
An interesting alternative using allyl alcohols utilising Ti(OiPr)4 has been reported by 
Hung and Yang.77 
 
Scheme 44: Pd(OAc)2 and Ti(OiPr)4. 
2.14	  Synthesis	  of	  2.58	  
On this basis the synthesis of both 2.58 and 2.59 was required.  
 
Scheme 45: Required Synthons for π-­‐Allyl Palladium Approach. 
Using the same procedure as for the production of 2.36, treatment of ten equivalents 
of allyl alcohol with one equivalent of vinyl glycine 2.16 with 2.20 10mol% yielded 
none of the desired CM product 2.58. This could be attributed to a reported non-
metathetic process of the degradation of terminal allyl alcohols to methyl ketones first 
reported by Hoye and Zhao.78  
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Hoye and Zhao discovered, whilst conducting systematic studies on allylic substituent 
effects on the RCM of substrates of type 2.60, that two products were formed 2.64 
and 2.65 in ratio of 2:3. An interesting side-reaction occurred that induced the overall 
transformation of 2.60 to 2.65, postulated to occur through the mechanism outlined in 
Scheme 46.    
 
 
Scheme 46: Proposed Mechanism of Grubbs Catalysed Isomerisation. 
Under identical conditions, treatment of ten equivalents of allyl acetate and one 
equivalent of vinyl glycine 2.16 with 2.20 10mol%, yielded 36% of the desired CM 
product 2.59. This low yield could be attributed the classification of allyl acetate as 
Type 2 with respect to 2.20 since approximately 60% of the allyl acetate homodimer 
was isolated. 
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CO2Me
HN OBn
O
AcO
2.59
CO2Me
HN OBn
O
2.16
Reagents and Conditions: 2.20 (10mol%), Allyl Acetate, CH2Cl2, 40oC, 18hr, 36%  
Scheme 47: Synthesis of 2.59 
2.15	  π-­‐Allyl	  Palladium	  Route	  to	  1.60	  
Attempts to couple 2.36 or 2.59 with 2.41 under a variety of the reported conditions 
for palladium catalysed allylic aminations unfortunately only resulted in diene 2.66 in 
around 75% yield and none of the desired radical precursor 1.60.  
Br
NHAc
CO2Me
HN OBn
O
R
2.35 R=Br
2.58 R=OAc
2.40
Br
N
Ac
CO2MeNH
CO2Bn
1.60
3
2
1
O
O
BnO2CHN
2.66
Reagents and Conditions: See Table 2  
Scheme 48: Palladium Catalysed Coupling Towards 1.60 
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Entry Compound  Reagents and Conditions Product Yield/ % 
1 2.36 Pd2(dba)3, dppb,  2.66 78 
2 2.36 NaH, Pd(OAc)2, PPh3, K2CO3, MeCN 2.66 72 
3 2.36 NaH, Pd(OAc)2, PPh3, K2CO3, THF 2.66 75 
4 2.36 Pd2(dba)3, SPhos, NaH 2.66 81 
5 2.59 Pd2(dba)3, dppb,  2.66 76 
6 2.59 NaH, Pd(OAc)2, PPh3, K2CO3, MeCN 2.66 75 
7 2.59 NaH, Pd(OAc)2, PPh3, K2CO3, THF 2.66 71 
8 2.59 Pd2(dba)3, SPhos, NaH 2.66 79 
Table	  2:	  Results	  of	  Palladium	  Catalysed	  Allylic	  Amination.	  
2.16	  Discussion	  of	  1H-­‐NMR	  of	  2.66	  
 
The 1H-NMR spectrum of 2.66 (The atoms are numbered in Scheme 48) is delineated 
in Figure 4. The indicative regions are: the a doublet (J=11.2Hz) at 7.00 ppm that is 
assigned to H-3, a doublet of triplets (J=17.0 and 10.7Hz) at 6.59ppm which is 
attributed to H-2, a singlet at 6.41ppm from the NH, a doublet (J=16.9Hz) at 5.60ppm 
assigned to H-1E and a doublet (J=10.0Hz) at 5.48 ppm from H-1Z. 
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Figure 4: 1H-NMR Spectrum of 2.66 
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2.17	  Retrosynthesis	  Part	  III	  
On further retrosynthetic inspection of 1.60, it was considered that if the terminal 
olefin was masked, to avoid undesired side reactions, then the double bond of the 
aniline side chain could be disconnected using the alkene metathesis strategy leading 
to intermediates 2.67 and 2.68. The reintroduction of the required functionality is 
possible through either the methyl ester 2.67, where addition of MeLi will install the 
desired dimethyl geminal unit as tertiary alcohol or via the methyl ketone 2.68 where 
either addition of MeLi or a Wittig reaction will establish the desired functionality. 
This approach would hopefully prevent the oxidation problems previously 
encountered with 2.26 would be avoided since the familiar CM strategy would be 
implemented afterwards. Both compounds 2.67 and 2.68 are available via a Wittig 
reaction from previously synthesised aldehyde 2.31. 
 
Scheme 49: 3rd Generation Retrosynthesis of α-CPA 1. 
2.18	  Synthesis	  of	  Methyl	  Ester	  2.67	  	  
Treatment of aldehyde 2.31 with the required phosphorane produced methyl ester 
2.67 in 89% yield. Several sets of conditions were tried for the conversion of 2.67 to 
the tertiary alcohol 2.69.  
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Scheme 50: Synthesis of Methyl Ester 2.67. 
2.19	  Addition	  of	  Methyllithium	  to	  2.67	  
OMeO
Br
N
Ac
Br
N
Ac
OR
2.67 2.69 R=H
2.70 R=TBS
1.
Reagents and Conditions: 1) See Table 3  
Scheme 51: Attempted Synthesis of Tertiary Alcohol 
 
Initially compound 2.67 was dissolved in THF and cooled to -78oC; 2.2 equivalents of 
methyllithium was added dropwise and the newly formed bright yellow solution was 
allowed to warm to 0oC upon which it turned to a murky brown mixture, possibly due 
to THF decomposition; α−deprotonation followed by a retro 2+3 cycloaddition 
yielding ethylene and the enolate of acetaldehyde.79 TLC analysis revealed a multi 
component mixture the separation of which was worthless. Following a protocol 
published by T. A. Chevchouk et al.80 methyllithium was added to diethyl ether and 
cooled to 0oC, addition of a solution of 2.67 in diethyl ether immediately resulted in 
the brown murky mixture observed previously. The first method was modified by 
quenching at -78oC with a pre-cooled saturated ammonium chloride solution, TLC 
analysis revealed a significantly cleaner reaction. Isolation by standard methods 
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produced a bright yellow oil which decomposed rapidly. It thought that possibly the 
tertiary allylic alcohol was possibly eliminating to the unstable triene 2.31. A 
potential inhibition of this suspected elimination would be the protection of the 
potentially formed alcohol functionality 2.69 as the silyl ether 2.70. 
 
A report by Corey and co-workers suggests that the best reagent for the protection of 
tertiary alcohols is tert-butyldimethylsilyl triflate.81 On this basis using the original 
approach, once TLC analysis revealed complete consumption of starting material 
approximately 30 minutes after the final addition of methyllithium, four equivalents 
of 2,6-lutidine followed by three equivalents of TBSOTf were added; unfortunately 
this resulted in the familiar multicomponent mixture after work up. 
 
 
 
Entry Reagents and Conditions Yield 
1 MeLi (2.2 eq), THF, -78oC to 0oC Decomp. 
2 MeLi (2.2 eq), Et2O, 0oC Decomp. 
3 MeLi (2.2 eq), THF, -78oC then sat.NH4Cl(aq.), -78oC   Decomp. 
4 MeLi (2.2 eq), THF, -78oC,  2,6-lutidine (4.0 eq), TBSOTf (3.0 eq) Decomp. 
Table	  3:	  Results	  of	  Attempted	  Dimethylation	  of	  2.67.	  
 
2.20	  Synthesis	  of	  Methyl	  Ketone	  2.68	  
Due to the difficulty encountered in transforming α,β-unsaturated methyl ester 2.67 
into either tertiary alcohol 2.69 or silyl ether 2.70, methyl ketone 2.68 was explored. 
Under standard conditions aldehyde 2.30 was converted in to methyl ketone 2.68 in 
92% yield. 
 
 
 50 
 
Scheme 52: Synthesis of Methyl Ketone 2.68. 
2.21	  Indolic	  Oxidation	  
At this stage in the project there was a concern about the installation of the indolic 
double bond after radical cyclisation. It has been demonstrated by Parsons et al. that 
tetracycle 2.71 can be oxidised to 2.72 but in a low yield.25, 26 It has also been found 
that 2.71 was aerially oxidised to 2.72 during amide hydrolysis after two weeks. 
 
Scheme 53: Indolic Oxidation 
2.22	  Indolinone	  Strategy	  
Due to low yield observed during the transformation of 2.71 to indole 2.72 it was 
thought that if an indolinone 2.73 was prepared, protection of the amide as an 
iminolether 2.74, followed by reduction of the iminolether with sodium 
cyanoborohydride would yield the unstable aminoalcohol 2.75 which would 
spontaneously aromatise to indole 2.76. This premise has a secondary advantage, if 
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the iminol ether was installed prior to the radical cyclisation, since the precursor 
would be held in a rigid conjugated system topographically assisting the reaction.  
 
Scheme 54: Proposed Indolinone to Indole Strategy. 
To test this hypothesis, firstly acrylamide 2.77 was synthesised by traditional 
methods. Acryloyl chloride was freshly prepared by treatment of acrylic acid with 
oxalyl chloride in dichloromethane followed by removal of unreacted oxalyl chloride 
under reduced pressure.82 The acid chloride was then dissolved in CH2Cl2, 
triethylamine was added followed by aniline 2.08, yielding acrylamide 2.77 in 80 % 
yield. Deprotection with HF and subsequent oxidation with MnO2 yielded 2.49 in 
79% yield from silyl ether 2.77. 
 
Scheme 55: Synthesis of Benzaldehyde 2.79 
Benzaldehyde 2.79 was elaborated to both the methyl ester 2.80 and methyl ketone 
2.81. 
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Scheme 56: Synthesis of 2.80 and 2.81 
With silyl ether 2.77, methyl ester 2.80 and methyl ketone 2.81 in hand, the formation 
of an iminol ether such as 2.74 was investigated.  
2.23	  Synthesis	  of	  Iminol	  Ethers	  
The synthesis of silyl iminol ether 2.83 was first reported by Ghosez and co-
workers,83 utilised as a diene in hetero-Diels-Alder reactions. 
HN
O
O
N
OTBS
OTBS
Reagents and Conditions: 1) TBSOTf, NEt3, Et2O, 86%
2.82 2.83
1.
 
Scheme 57: TBSOTf and NEt3 in Et2O. 
Takasu et al. using sodium hydride and tert-butyldimethyl silyl chloride in THF have 
reported the construction of 1-aza-2-siloxybutadienes.84 
N
H
O N OTBS
Reagents and Conditions: 1) NaH (1.0 eq), THF, rt then TBSCl (1.0 eq), rt,  69%
2.84 2.85
1.
 
Scheme 58: TBSCl and NaH in THF. 
Several methylating agents have also been described in the preparation of methyl 
imino ethers:  
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Scheme 59: MeOTf in CH2Cl2.85 
 
Scheme 60: Diazomethane in Diethyl Ether86 
 
Scheme 61: Meerweins’ salt in CH2Cl287 
These results encouraged our confidence in installing an iminol ether moiety. Intially 
compound 2.77 was investigated; unfortunately no iminol silyl ether was isolated 
under any of the published procedures. Treatment of 2.77 with Meerwein salt in 
ether55 resulted in deprotection of the silyl ether forming benzyl alcohol 2.78. 
Treatment of methyl ester 2.80 under silylating conditions only resulted in recovery of 
starting material. Both methyl ketone 2.80 and methyl ester 2.81 only produced 
starting material when treated with Meerweins’ salt. Table 4 
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Entry Compound Reagents and Conditions Product Yield/ % 
1 2.77 2,6-lutidine, TBSOTf, DCM SM N/A 
2 2.77 TBSOTf, NEt3, Et2O SM N/A 
3 2.77 TBSCl, NaH, THF SM N/A 
4 2.77 Meerweins’ salt, DCM 2.78 24 
5 2.80 2,6-lutidine, TBSOTf, DCM SM N/A 
6 2.80 TBSCl, NaH, THF SM N/A 
7 2.80 TBSOTf, NaH, THF SM N/A 
8 2.80 Meerwein’ salt, DCM SM N/A 
Table	  4:	  Results	  of	  Attempted	  Formation	  of	  an	  Iminol	  Ether.	  
2.24	  Retrosynthesis	  Part	  IV	  
An alternative approach would be to perform the cross metathesis first between either 
methyl ester 2.80 or methyl ketone 2.81 and vinyl glycine derivative 2.16 and once 
indolinone 2.92 or 2.93 had been synthesised there would be more options to 
transform it into the required indole. Following the same retrosynthetic analysis 2.92 
or 2.93 would be prepared by a radical cyclisation from its respective precursor, 
available from previously synthesised 2.80 or 2.81.  
 
Scheme 62: 4th Generation Retrosynthesis of α-CPA 1. 
With this strategy in mind, tertiary alcohol 2.96 was required since it already contains 
the necessary geminal dimethyl unit prior to radical cyclisation. Tertiary alcohol 2.96 
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was prepared in 82% yield by addition of two equivalents of methyllithium to a 
solution of methyl ketone 2.81 at -78oC. 
2.25	  X-­‐Ray	  Crystal	  Structure	  of	  Tertiary	  Alcohol	  
Compound 2.96 crystallised from a diethyl ether/hexane mixture and the structure 
was confirmed by X-ray analysis, it has triclinic crystal system and belongs to the P   
(No.2) space group. There are two independent molecules with essentially the same 
geometry with hydroxyl hydrogen atoms disordered over two sites. 
 
Figure 5: ORTEP Drawing of Tertiary Alcohol 2.96. 
2.26	  Formation	  of	  Triene	  2.97	  
Protection of allylic alcohol 2.96, resulted in the formation of triene 2.97 in 22% 
yield. It is assumed that this came from the production of triflic acid, protonating 
alcohol 2.96 resulting in elimination of water to create a tertiary allylic cation which 
loses a proton forming triene 2.97. 
 
Scheme 63: Synthesis of Triene 2.97 
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2.27	  Cross	  Metathesis	  of	  Acetamide	  2.81	  
The proposed cross metathesis was initially tested on methyl ester 2.80; treatment of 
2.80 and 2.16 with 10mol% of Grubbs second generation catalyst 2.20 in 
dichloromethane for eighteen hours showed by TLC analysis the formation of one 
major polar product and remaining starting material. Isolation by column 
chromatography followed by trituration with pentane yielded a white solid. 1H-NMR 
spectroscopy showed three indicative peaks but unfortunately not of the desired 
product. During the course of the reaction after the cross metathesis had occurred, 
isomerisation of the double bond took place leading to eneamine 2.98 in 63% yield. 
 
 
Scheme 64: Isomerised CM Product 
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2.28	  Discussion	  of	  the	  1H-­‐NMR	  of	  2.98	  
Figure 6: 1H-NMR of eneamine 2.98 
The 1H-NMR of eneamine 2.98 is delineated above, instead of the expected AX 
system for the trans alkene normally formed from a CM; an A2X system was 
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observed, between the doublet (J=7.6Hz) at 3.42ppm and the triplet at 6.83ppm 
J=7.7Hz), which is indicative of the CH2CH proposed. An additional refining factor is 
the shift of the NH signal from 5.40ppm to 6.71ppm due to the conjugation, of the 
nitrogen lone pair with the double bond, introduced by the isomerisation.  
2.29	  Non-­‐Metathetic	  Reactions	  of	  Grubbs	  Alkene	  Metathesis	  
As previously noted there have been numerous non-metathetic reactions reported in 
the literature, Alcaide and Almendros have reported a useful summary of these 
reactions.88 Snapper et al. reported the first non-metathetic process catalysed by the 
classical Grubbs’ ruthenium benzylidene complex 2.17, whilst conducting an 
investigation into cross metathesis observed complete chemo- and regioselective 
addition of chloroform across mono- and 1,1-disubstituted alkenes.89  
 
 
Scheme 65: Grubbs I Catalysed	  Kharasch	  Reaction.	  
In relation to the isomerisation observed leading to compound 2.98, it has been 
reported that tertiary allylamines can be readily deprotected in the presence Grubbs I 
2.17.90 
 
Scheme 66: Grubbs I Catalysed Allyl Amine Deprotection. 
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The mechanism of the conversion of 2.102 to 2.103 has been investigated by 1H-
NMR studies.  When generic allyl amine 2.104 is treated with first generation Grubbs 
catalyst intermediate 2.105 is formed. Two mechanistic pathways have been 
proposed: the first involves an intermolecular reaction forming diamine 2.106 which 
collapses to reform intermediate 2.105 and eneamine 2.107, which upon treatment 
with silica gel degrades to secondary amine 2.110. The alternative is identical to the 
mechanism proposed by Hoye and Zhao78 in which compound 2.105 isomerises to 
eneamine 2.108 followed by cleavage of the ruthenium-carbon bond giving vinyl 
amine 2.109 which decomposed to amine 2.110 when treated with silica gel. The 1H-
NMR studies showed disappearance of the vinylic protons of 2.104 followed by 
appearance of an indicative methyl peak signifying that an intermediate of type 2.107 
was formed.  
 
Scheme 67: Proposed Mechanism of Deprotection 
2.30	  Inhibiting	  Non-­‐Metathetic	  Reactions	  of	  Grubbs	  Alkene	  Metathesis	  
There have been numerous papers by several research groups reporting attempts to 
inhibit the non-metathetic behaviour of Grubbs catalyst by the use of various 
additives. Meyer and co-workers have utilised tin and iron halogenides to suppress the 
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isomerisation of olefins in metathesis.91 Chlorocatecholborane92 and 2,6-
dichlorobenzoquinone93 have all been used in the cross metathesis of cyclic α-
methylene-β-lactones successfully inhibiting the formation of the thermodynamically 
favoured α,β−unsaturated lactone. Phenylphosphoric acid has also been reported as a 
new additive in the self-metathesis of urea-substituted alkenes, impeding 
isomerisation.94 
 
2,6-Dichlorobenzoquinone was initially chosen due to its immediate availability; 
although it did not arrest the formation of 2.98 it did ease purification of the product 
and slightly increase the yield to 70%. Chlorocatecholborane produced a similar 
result.  
 
It was postulated that once the cross metathesis has occurred the pKa of the α-amino 
proton is decreased due the conjugation of the anion formed with the acrylamide unit, 
creating an electron sink which facilitates the isomerisation. Since no isomerised 
product was observed when an allyl amine derivative was used it was decided to 
revert back to this synthetic route. 
 
Methyl ketone 2.68 and methyl ester 2.67 were subjected to various conditions to 
optimise the cross metathesis. Initially methyl ester 2.67 was combined with vinyl 
glycine 2.16 in the presence of 10mol% of Grubbs II on a mmol scale for TLC 
studies, the reaction was re peated with the addition of 10mol% 
dichlorodicyanoquinone which by TLC showed a much cleaner reaction as observed 
previously when attempting to inhibit the isomerisation of 2.98. The reaction was 
scaled up under these conditions.  
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An issue had arisen when considering the next synthetic step, obvious simply from 
the visual appearance of the product. This is a persistent pertinent problem associated 
with Grubbs catalyst: the removal of residual ruthenium from the products obtained.  
2.31	  Ruthenium	  Removal	  From	  Metathesis	  Products	  
Several research groups have made efforts to remove the remaining ruthenium. 
Grubbs and Maynard were first to recognise this problem using the water soluble 
tris(hydroxymethyl)phosphine in dichloromethane and triethylamine.95 Unfortunately 
this method requires at least 86 equivalents of the expensive reagent. The use of toxic 
Pb(OAc)4 was reported in 2000.96 Georg and co-workers have reported the use of 
triphenylphosphine oxide or DMSO as a viable method that suffers from the 
drawback of necessitating stirring 50 equivalents of reagent for 24 hours.97 Amine-
functionalized mesoporous silicates have be found to be excellent ruthenium 
scavengers.98 The most recent procedure reported utilises a polar isocyanide.99 
 
The initial choice was triphenylphosphine oxide originally due to immediate 
availability. It was decided to test this method of removal on the precursor to the cross 
metathesis recovered from the metathesis reaction. Compound 2.68 was stirred with 
fifty equivalents of Ph3P=O for twenty-four hours. After column chromatography 
there was a substantial difference in the appearance of the product going from a 
brown colour to translucent white. Unfortunately this method of residual ruthenium 
removal was not successful with the products from the cross metathesis due to 
similarity in Rf of both the triphenylphosphine oxide and the cross metathesis product. 
The next method chosen was to try to implement the polar isocyanide 2.113, available 
from formate 2.111. 
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Scheme 68: Synthesis of Polar Isocyanide 
This method was tested on recovered starting material 2.68 and proved to be 
successful. The procedure was transferred to radical precursors 2.114 and 2.115 
removing the residual ruthenium competently.  
R O
Br
N
Ac
R O
Br
N
Ac
CO2MeHN
CO2Bn
2.67 R=OMe
2.68 R=Me
2.114 R=OMe
2.115 R=Me
1.
Reagents and Conditions: 1) See Table 5
Scheme 67  
Scheme 69: Synthesis of Radical Precursor 
Substrate Reagents and Conditions Product Yield / % 
2.67 Grubbs II (10mol%), DDQ (10mol%), CH2Cl2, 
40oC, 18hr, then CNCO2K, rt 5mins. 
2.114 43  
2.68 Grubbs II (10mol%), DDQ (10mol%), CH2Cl2, 
40oC, 18hr, then CNCO2K, rt 5mins. 
2.115 46 
Table	  5:	  Results	  for	  the	  Formation	  of	  2.114	  and	  2.115.	  
 
Finally with the desired radical precursors in hand our attention was turned to the 
radical cyclisation. 
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2.32	  Executing	  Radical	  Reactions	  
When undertaking a radical reaction several factors must be taken into consideration. 
Using highly dilute solutions ca. 0.01M inhibits intermolecular reactions leading to 
polymeric species. The elimination of radical acceptors and therefore terminators of 
the required reaction from the reaction medium is essential, to accomplish this 
solvents must be degassed prior to the reaction by the freeze-thaw method and purged 
with nitrogen. Additionally suba-seals should be used with caution; they should never 
come into contact with refluxing solvents, so in this instance should only be inserted 
at the top of the reflux condenser. The concentration of tributyltin radicals at anytime 
is a pertinent issue, ideally this would be constant throughout the reaction. Current 
methods to achieve this scenario are either the use of a syringe pump to add a solution 
of AIBN and Bu3SnH slowly at a rate that is consistent with the reaction rate, or the 
use of a reductive catalytic system.  
 
The reductive catalytic method was first utilised in a cascade sequence by Stork et 
al.100 A publication by Kuivila and Menapace noting the reduction of alkyl halides in 
the presence of lithium aluminium hydride and alkyl tin halides,101 incited Corey and 
co-workers to develop the milder procedure, due to their interest in prostaglandin 
synthesis, to reductively dehalogenate an advanced intermediate.102 
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2.33	  Synthesis	  of	  Model	  Tricycles	  
In order to gain familiarity and to compare the effectiveness of the procedures, the 
radical reactions were tested on methyl ester 2.67 and methyl ketone 2.68.  
R O
Br
N
Ac
N
Ac
OR
H
2.67 R=OMe
2.68 R=Me
2.116 R=OMe
2.117 R=Me
Reagents and Conditions: 1) See Table 6  
 Scheme 70: Synthesis of Test Tricycles 
 
Substrate Reagents and Conditions Product Yield/ % 
2.67 SnBu3Cl (0.1eq), NaCNBH3 (2eq), AIBN, 
tBuOH, 80oC, 18hr. 
2.116 56 
2.67 SnBu3H, AIBN, PhMe, 110oC, 18hr. 2.116 71 
2.68 SnBu3Cl (0.1eq), NaCNBH3 (2eq), AIBN, 
tBuOH, 80oC, 18hr. 
2.117 53 
2.68 SnBu3H, AIBN, PhMe, 110oC, 18hr. 2.117 73 
Table	  6:	  Results	  of	  Model	  Studies.	  
 
 
Examination of molecular models indicates the most likely relative stereochemistry of 
H-2 and H-4 is cis. The relative stereochemistry represented above can be rationalised 
by the mechanism delineated below. Once the first cyclisation has occurred it can be 
said that the hydrogen of 2.118 is pointing down. Consequently, once the subsequent 
cyclisation occurs, the primary radical of the methyl group is pointing up, attacking 
from above maintaining maximum p-orbital overlap and H-4 is forced down. The 
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resulting benzyl radical is quenched to give the cis indloine 2.117. This deduction is 
supported by 1H-NMR, the pseudo quartet at δ 1.49 ppm is typical of systems with H-
2, H-4 cis stereochemistry.103,104 
OMe
Br
N
O
N
OMe
O
2.68
N
O
Me O
2.1192.118
N
1
O
2
3
4
H
Me O
H
2.117  
Scheme 71: Rationale of Proposed Relative Stereochemistry. 
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2.34	  Discussion	  of	  1H-­‐NMR	  data	  of	  2.116	  and	  2.117	  
The 1H-NMR of the methyl ester analog 2.116 is pictured below. 
 
Figure 7: The 1H-NMR spectrum of 2.116. 
 
 
 
 67 
The 1H-NMR of the methyl ketone analog 2.117 is pictured below. 
 
Figure 8: The 1H-NMR spectrum of 2.117. 
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Proton 
Chemical 
Shift (ppm) Mutliplicity 
Coupling 
Constant (Hz) 
H-1α 4.25 t' 9.2 
H-1β 3.61 t' 10.5 
H-2β 3.25 m   
H-3α 1.49 q' 11.7 
H-3β 2.4 dd 12.2, 9.2 
H-4β 3.41 dd 11.7,11.4 
H-5α 2.83 dd 16.7,11.4 
H-5β 3.09 dd 16.7,6.1 
Table	  7:	  NMR	  data	  of	  2.117	  
 
5 2
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4
NAc
1
Hβ
Hα
Hβ
Hα
Hβ
Hβ
RHα
Hβ
 
Figure 9: Conformer of 2.117. 
The data extracted from the 1H-NMR of 2.117 is summarised in the table above and 
2.117 drawn in the conformer above helps explain this data. The signals for both H-
1α and H-1β appear as pseudo triplets at 4.25 and 3.61ppm respectively, it would be 
expected that they would both appear as a doublet of doublets; for H-1α due to the 
geminal coupling between H-1α and H-1β and an axial-axial vicinial coupling 
coupling between H-1α and H-2β.  H-1β has the same geminal coupling between H-
1α and H-1β and an axial-equatorial vicinial coupling between H-1β and H-2β.  H-2β 
appears as an unresolved multiplet at 3.25ppm. H-3α is a pseudo-quartet (J=11.7Hz) 
at 1.49ppm this is due to two axial-axial vicinial couplings between H-3α and H-
2β plus H-3α and H-4β, in addition to the geminal coupling between H-3α and H-3β.  
H-3β signal has been resolved as a doublets of doublets (J=12.2 and 9.2Hz) the 
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coupling constant of 12.2Hz for the geminal coupling between H-3α and H-3β. H-3β 
should also couple with both H-2β and H-4β in an axial-equatorial vicinial manner. 
The coupling constant observed of 9.2Hz is for one of these. H-4β signal 3.41ppm has 
been resolved as a doublet of doublets of doublets (J=11.7, 11.4 and 6.1Hz), The 
coupling constant observed of 11.7Hz is for the axial-axial vicinial coupling between 
H-3α and H-4β and the coupling constant observed of 11.4Hz is for the axial-axial 
vicinial coupling between H-5α and H-4β, the coupling constant of 6.1Hz is from an 
axial-equatorial vicinial coupling between H-4β and H-5β. H-5α appears as a doublet 
of doublets (J=16.7 and 11.4Hz) at 2.83ppm, the large coupling constant of 16.7Hz is 
a result from the geminal coupling between H-5α and H-5β.  The coupling constant 
observed of 11.4Hz is for the axial-axial vicinial coupling between H-5α and H-4β. 
H-5β appears as a doublet of doublets (J=16.7 and 6.1Hz), as discussed the coupling 
constant of 16.7Hz is for geminal coupling between H-5α and H-5β. Τhe smaller 
coupling contant of 6.1Hz is from an axial-equatorial vicinial coupling between H-
4β and H-5β. This data is consistent with the diastereoisomer displayed. 
2.35	  Synthesis	  of	  Amide	  Analogue	  	  
On the basis of the results obtained it was decided that slow addition of a tributyltin 
hydride solution via a syringe pump would be the method implemented on substrates 
2.114 and 2.115. Unfortunately 2.115 gave an inseparable multi-spot component 
mixture, however methyl ester 2.114 gave 74%, based on recovered starting material, 
of a diastereomeric mixture of 2.220. TLC analysis showed four compounds.  
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Scheme 72: Synthesis of Key Tricylcle 
Unfortunately the products obtained from the reaction were very difficult to purify, 
although TLC analysis would show a retention factor of 0.22 when 10% 
NH4OH/MeOH:CH2Cl2 (1:99) was used, if this solution was used to elute a column 
for flash chromatography it would result in all of the products flushing out in under 
five tubes. Subsequently the column was eluted with (1:200), which by TLC analysis 
showed no movement of the substrate from the baseline, allowed for a partial 
separation of the diastereoisomers. The product was subjected to several purifications 
by chromatography, however all attempts were futile in attempting to isolating the 
individual diastereoisomers, the gradual loss of product in attempts to purify led to 
exploring an alternative approach. 
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2.36:	  Discussion	  of	  1H-­‐NMR	  data	  of	  2.220	  
 
Figure 8: 1H-NMR of 2.220 
 
The 1H-NMR of 2.220 of is far more difficult to interpret than the spectra of 2.117. It 
does indicatively show that olefinic signals have disappeared. The two sets of 
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doublets previously recorded at 8.06 and 6.40ppm and the multiplet and doublet 
observed at 5.84 and 5.51ppm respectively are also absent.  
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Figure 10: Proposed Diastereisomer of 2.220 
A proportion of the signals observed from the 1H-NMR of 2.220 do give some 
information about one of the possible diastereoisomers produced, delineated above in 
Figure 9: A triplet of doublets (J=11.9 and 5.6Hz) is observed at 2.74ppm, this signal 
could be attributed to H-3α, with two similar axial-axial vicinial couplings between 
H-3α and H-2β plus H-3α and H-4β producing the triplet and the doublet from 
coupling with the proton of the amino acid side chain. A doublet of doublets (16.9 and 
11.8Hz) at 2.82ppm, a similar signal observed in 1H-NMR spectrum of 2.117, can be 
attributed to H-5α.  The coupling constant of 16.9Hz is a result from the geminal 
coupling between H-5α and H-5β.  The coupling constant observed of 11.8Hz is for 
the axial-axial vicinial coupling between H-5α and H-4β. A doublet of doublets (16.9 
and 5.9HZ) at 3.30ppm is assigned to H-5β,  the coupling constant of 16.9Hz is for 
geminal coupling between H-5α and H-5β. Τhe smaller coupling contant of 5.9Hz is 
from an axial-equatorial vicinial coupling between H-4β and H-5β. This data is 
indicates the diastereisomer displayed above, although more extensive NMR studies 
need to be conducted. 
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2.37	  Attempted	  Oxidation	  of	  Amide	  Analogue	  
It was decided that it could be possible to simplify the situation if one of the 
stereogenic centres was removed by the oxidation of indoline 2.220 to indole 2.221. 
 
Scheme 73: Oxidation of Indoline 2.220 
Research of the literature disclosed several suitable protocols. The desired 
transformation was initially used by Barrett and co-workers at Imperial college, 
London, who developed the concept of latent aromatocity.105 Barrett et al. used to 
DDQ as mild oxidant of advanced penicillin intermediate 2.222. However model 
studies on simpler systems, in respect of regenerating the dormant acid, indicated that 
the basic conditions required for the deprotection were not compatible with the real 
system.  
 
 
Scheme 74: DDQ oxidation 
This idea has been extended and applied in the total synthesis of the complex CP 
molecules by Nicolaou and Co-workers.106 Impressively the protection group was 
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implemented in the total synthesis of CP-255,915 and CP-263,114, allowing the  
protection of a highly developed intermediate. Following intense investigation it was 
found that p-chloroanil was the most successful reagent in promoting the desired 
transformation, and hence realising the totynthesis of this notable target. 
 
The use of manganese(III)acetate in acetic acid has been reported by Ketcha.107, The 
harsh conditions required to promote the reaction were deemed inappropriate for 
substrate 2.220 when considering the complex nature of the starting material. 
 
DDQ and p-chloroanil were tested on substrate 2.220; unfortunately neither reaction 
was capable of effecting the transformation. 
Future	  Work	  
2.38	  Completing	  of	  Amide	  Analogue	  of	  α−CPA	  	  
Completion of the project, in respect to the current route, could multitple directions. 
There are four transformations required to complete the synthesis of the amide analog. 
Firstly the deprotection of the benzyl carbamate, typically achieved with H2/Pd-C in 
MeOH,108 109 alternatively Me3SiI in acetonitrile110 or triethylsilane in ethanol with a 
catalytic amount of triethylamine111 and Pd(OAc)2.112 This would be followed 
secondly by condensation of the newly formed primary amine with the proximal ester 
moiety possibly assisted by Lewis acid catalysis. Thirdly the indoline functionality 
could be oxidised to an indole using one of the methods previously discussed; 
subsequent deprotection of the acetamide functionality is necessary. The order of 
these steps could be altered. Once amide 2.228 is obtained the synthesis will follow 
the same sequence as previously published. 
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Scheme 75: Steps Required for the Completion of Amide Analogue of α−CPA	  1.01 
2.39	  Completing	  the	  Total	  Synthesis	  of	  α−CPA	  	  
To complete the synthesis of a-CPA 1.01 it is necessary to optimise the radical 
cyclisation of methyl ketone 2.115 to tricycle 2.230. Two approaches are envisaged: 
deprotection of the amine followed by condensation with ketone to form imine 2.231 
an intermediate that is an indoline version of 1.36. Addition of a methyl anion to  
ketimine 2.231 will furnish intermediate 2.233, that could be subjected a similar 
sequence to that outlined for 2.229. Alternatively 2.230 could be transformed to 
2.232, through a Wittig reaction, which upon exposure to acid will cyclise via a 
tertiary cation to 2.233.  
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Scheme 76: Future work for the Total Synthesis of a-CPA 1.01 
2.40	  Macrocyclic	  Radical	  Cascade	  Approach	  to	  α−CPA	  
When considering the diastereomeric mixture obtained from the radical cascade of 
2.114, an alternative complimentary route could be investigated. Utilising previously 
synthesised aldehyde 2.30 in a Horner-Wadworth-Emmons reaction with 2.334, 
which can be derived from vinyl glycine, would give triene 2.335. Subjecting 2.335 to 
Grubbs catalyst will provide macrocycle 2.336. The asymmetrically constrained 
transition state would yield the desired precursor, through a transannular  cyclisation, 
in a homochiral form.  
 
 
 77 
 
Scheme 77: A Transmolecular Cylisation Approach to α−CPA	  1.01	  
2.41	  A	  New	  Approach	  to	  α−CPA	  
A final approach to a-CPA 1.01 has been designed. If intermediate 2.337 was 
synthesised, treatment with NCS followed by addition of SnBu3H would yield a 
nitrogen radical that would spontaneous macrocyclise onto the alkene. Subsequent 
reaction of the secondary radical 2.338 onto the alkyne would give alkenic radical 
2.339. H-abstraction followed by cyclisation would yield advanced tetracycle 2.341. 
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Scheme 78: A New Approach to a-CPA 1.01 
2.42	  Conclusion	  
Thorough investigation has developed a successful route to the desired radical 
precursor. The proposed radical cascade has been tested and proved successful on a 
potential amide analogue of a-CPA 1.01; however, the diastereomeric mixture 
obtained may indicate a different direction may have to be pursued. The macrocyclic 
transmolecular approach outlined in Scheme 77 should be explored since it would 
solve the diastereomeric dilemma. 
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Experimental 
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3.1	  General	  Procedure	  
Reactions were conducted at room temperature under an atmosphere of nitrogen 
unless otherwise stated. Reactions were monitored using analytical thin-layer 
chromatography with visualisation by UV light and either alkaline potassium 
permanganate (KMnO4), vanillin, or phosphomolybdic acid (PMA) dips. 
 
Reaction solvents were purified and dried according to literature methods. THF and 
diethyl ether were distilled from sodium with benzophenone as an indicator, CH2Cl2 
and acetonitrile were distilled from CaH2. The use of hexanes refers to distilled 
petroleum 40-60ºC. All other solvents and reagents were used as supplied. Flash 
chromatography was performed using silica gel 60, 230-400 mesh.  
 
1H NMR spectra were recorded on a Bruker 300MHz or a Varian 500MHz machine 
(operating at ambient probe temperature using an internal deuterium lock). Chemical 
shifts were reported in parts per million (ppm), using residual solvent as an internal 
standard. Standard abbreviations were used throughout (s singlet; bs broad singlet; d 
doublet; dd doublet of doublets; dt doublet of triplets; dq doublet of quartets; t triplet; 
q quartet; m multiplet). Coupling constants were measured in Hertz (Hz). 13C NMR 
spectra were recorded at 126 MHz. Chemical shifts are reported in parts per million 
(ppm); m, M or m/M denotes either the major or minor diastereomer (or both as a 
combined signal).  
 
ESI Mass spectra were recorded on a Bruker Daltonics Apex III spectrometer with 
methanol as solvent. EI mass spectra were recorded on a Fisons VG Autospec 
spectrometer. Infra red spectra were recorded on a Perkin Elmer Spectrum One FT-IR 
spectrometer. Alpha-D were recorded on a AUTOPOL IV Polarimeter at an ambient 
temperature of 23oC. 
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2.06:	  2-­‐Bromo-­‐3-­‐nitrobenzoic	  acid	  	  
 
The title compound was prepared using the method Culhane et al.52  (52.12g, 74%) 
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2.07:	  2-­‐Bromo-­‐3-­‐nitrobenzyl	  alcohol	  	  
2
3
4
1
Br
NO2
OH
 
To a stirring solution of 2-bromo-3-nitrobenzoic acid 2.06 (51.32g, 209mmol) in THF 
200ml at 0oC to this a solution of BH3.THF (1.0M, 418ml, 418mmol) was added 
dropwise maintaining the temperature below 2oC. Once addition was complete the 
solution was stirred for an hour at 0oC and then allowed to warm to room temperature. 
The solution was added to ice in water (200ml) followed by addition of K2CO3 until 
saturated. The organic layer was separated and the aqueous phase was washed with 
Et2O (3x100ml). The organic extracts were combined and the solvent was removed 
under reduced pressure. The crude extract was purified by column chromatography 
(PE:Et2O, 3:2) to give 2-bromo-3-nitrobenzyl alcohol 2.07 (44.05g, 91%) as a white 
solid. 
 
1H NMR (300 MHz, CDCl3) δ: 7.61 (d, J = 7.1, 1H, H-4), 7.47 (d, J = 8.00, 1H, H-2), 
7.32 (t, J = 7.84, 1H, H-3), 4.65 (s, 2H, H-4), 2.05 (s, 1H, OH). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.03:	  3-­‐Amino-­‐2-­‐bromobenzyl	  alcohol	  	  
2
3
4
1
Br
NH2
OH
 
Iron powder (5.58g, 0.1mol) was added to a stirring solution of 2-bromo-3-
nitrobenzyl alcohol 2.07 (5.32g, 22.9mmol in glacial acetic acid (70ml) and absolute 
ethanol (70ml) and the mixture was refluxed for 3 hours. The mixture was allowed to 
cool to room temperature upon which water (100ml) was added and the solvents from 
the mixture were removed under reduced pressure. The mixture was washed with 
ethyl acetate (3x100ml), the combined extracts were washed with saturated sodium 
bicarbonate, dried with magnesium sulphate and the solvent was removed under 
reduced pressure. The crude extract was purified using column chromatography to 
give 3-amino-2-bromobenzyl alcohol 2.03 (3.47g, 75%) as a white solid. 
 
1H NMR (300 MHz, CDCl3) δ: 7.04 (t, J = 7.79, 1H, H-3), 6.81 (d, J = 7.1, 1H, H-4), 
6.43 (d, J = 8.00, 1H, H-2), 4.57 (s, 2H, H-4), 2.84 (s, 2H, NH), 2.15 (s, 1H, OH). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.08:	  2-­‐Bromo-­‐3-­‐(tert-­‐butyldimethylsilyloxymethyl)aniline.	  	  
4
5
6
3
Br
NH2
O
Si
2
1
 
To a stirring solution of 3-amino-2-bromobenzyl alcohol 2.03 (3.22g, 15.9mmol) 
imidazole (1.62g, 23.9mmol) and a catalytic amount of DMAP in anhydrous DMF 
(15ml) was cooled in an ice bath to 0oC. Once the mixture was homogeneous, tert-
butyldimethylsilylchloride (2.80, 18.6mmol) was added. The mixture was allowed to 
warm to room temperature and was allowed to stir for 18 hours. A saturated brine 
(15ml) solution was added to the mixture and the mixture was extracted with Et2O 
(3x15ml) and the combined extracts were dried with magnesium sulphate. The 
solvent was removed under reduced pressure to give a yellow oil. The crude extract 
was purified using column chromatography (PE:Et2O, 4:1) to give 2-bromo-3-(tert-
butyldimethylsilyloxymethyl)aniline 2.08 (4.63g, 92%) as a light yellow oil.  
 
1H NMR (300 MHz, CDCl3) δ: 7.12 (t, J = 7.84, 1H, H-5), 6.87 (d, J = 7.15, 1H, H-4), 
6.49 (d, J = 7.98, 1H, H-6), 4.59 (s, 2H, H-3), 3.76 (s, 2H, NH), 0.95 (s, 9H, H-1), 
0.06 (s, 6H, H-2). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.09:	  3-­‐(N-­‐Acetyl-­‐N-­‐allylamino)-­‐2-­‐bromobenzyl	  alcohol	  	  
4
5
6
3
Br
N
H
O
Si
2
1
7
8
9
 
A solution of LDA was freshly prepared from diisopropylamine (0.73ml, 5.21mmol) 
and n-butyllithium (1.0M, 3.67ml, 3.67mmol) in anhydrous THF (20ml) at 0oC was 
added dropwise via cannula to a stirring solution of 2-bromo-3-(tert-
butyldimethylsilyloxymethyl)aniline 2.08 (1.00g 3.16mmol) in anhydrous THF 
(50ml) at -78oC under a nitrogen atmosphere. The solution was allowed to warm to 
room temperature upon which a yellow solution formed. The solution was again 
cooled to -78oC and allyl bromide (0.29ml, 3.37mmol) was added dropwise. Once 
addition was complete the solution was allowed to warm to room temperature  and 
was stirred for a further 3 hours. A saturated ammonium chloride solution (50ml) was 
added and the organic layer was separated. The aqueous extract was washed with 
Et2O (3x30ml) and the combined extracts were dried with magnesium sulphate. The 
solvent was removed under reduced pressure. The crude extract was purified by 
column chromatography eluted with (PE:Et2O, 95:5),to give 3-(N-acetyl-N-
allylamino)-2-bromobenzyl alcohol 2.09 (0.81g, 72%) as a colourless oil. 
 
1H NMR (300 MHz, CDCl3) δ 7.18 (t, J = 7.79, 1H, H-5), 6.92 (d, J = 7.05, 1H, H-6), 
6.81 (d, J = 7.91, 1H, H-4), 5.91 (m, 1H, H-8), 5.30 (d, J = 17.0, 1H, H-9E), 5.13 (d, J 
= 10.7, 1H, H-9Z), 4.67 (s, 2H, H-3), 3.79 (m, 2H, H-13) 2.65 (s, 1H, NH), 0.92 (s, 
9H, H-1), 0.06 (s, 6H, H-2). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.10:	  2-­‐Bromo-­‐3-­‐(tert-­‐butyldimethylsilyloxxymethyl)-­‐N-­‐acetyl-­‐N-­‐allylaniline.	  	  
4
5
6
3
Br
N
O
Si
2
1
7
8
9
10O  
A solution of LDA was freshly prepared from diisopropylamine (0.73ml, 5.21mmol) 
and n-butyllithium (1.0M, 3.67ml, 3.67mmol) in anhydrous THF (20ml) at 0oC was 
added dropwise via cannula to a stirring solution of 2.08  2-bromo-3-(tert-
butyldimethylsilyloxymethyl)aniline (1.00g 3.16mmol) in anhydrous THF (50ml) at -
78oC under a nitrogen atmosphere. The solution was allowed to warm to room 
temperature upon which a yellow solution formed. The solution was again cooled to -
78oC and allyl bromide (0.29ml, 3.37mmol) was added dropwise. Once addition was 
complete the solution was allowed to warm to room temperature and was stirred for a 
further 3 hours. A saturated ammonium chloride solution (50ml) was added and the 
organic layer was separated. The aqueous extract was washed with Et2O (3x30ml) and 
the combined extracts were dried with magnesium sulphate. The solvent was removed 
under reduced pressure. The crude product was dissolved in anhydrous THF (40ml). 
Freshly distilled acetyl chloride (0.90ml, 12.6mmol) was added and the solution was 
stirred at room temperature for an hour. The solution was quenched with saturated 
sodium bicarbonate solution (40ml), the organic layer was separated and the aqueous 
extract was washed with ethyl acetate (3x50ml). The organic layers were combined, 
dried with magnesium sulphate and the solvent was removed under reduced pressure. 
The crude extract was purified by column chromatography (PE:Et2O, 1:1) to give 
2.10 2-bromo-3-(tert-butyldimethylsilyloxxymethyl)-N-acetyl-N-allylaniline (1.03g, 
82%) as a yellow oil. 
 
1H NMR (300 MHz, CDCl3) δ: 7.59 (t, J = 7.8, 1H, H-7), 7.08 (d, J = 7.13, 1H, H-4), 
6.90 (d, J = 7.94, 1H, H-6), 5.88 (m, 1H, H-8), 5.27 (d, J = 16.9, 1H, H-9E), 5.15 (d, J 
= 11.0 1H, H-9Z), 4.78 (s, 2H, H-4), 4.10 (m, 2H, H-7), 1.79 (s, 3H, H-10) 0.97 (s, 
9H, H-1), 0.04 (s, 6H, H-3). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.11:	  Tert-­‐butyl	  allyl[2-­‐bromo-­‐3-­‐({[tert-­‐
butyl(dimethyl)silyl]oxy}methyl)phenyl]carbamate	  	  
 
2-Bromo-3-({[tert-butyl(dimethyl)silyl]oxy}methyl)aniline (1.759g, 5.58mmol) was 
dissolved in THF (40ml) and cooled to -78oC under a nitrogen atmosphere. In a 
separate flask THF (10ml) was charged with nitrogen and DIPA (1.30ml, 9.21mmol) 
was added. The solution was cooled to -10oC. nBuLi (2.2M in hexanes, 2.54ml, 
5.58mmol) was added dropwise, maintaining the temperature below -5 oC. The 
solution was stirred for 10 minutes. The freshly formed LDA was added dropwise via 
cannula to the stirring solution of the aniline maintaining the temperature below -
75oC. Once all the LDA had been added the mixture was allowed to slowly warm to 
0oC. The yellow solution was cooled to -78oC. Freshly distilled allyl bromide (0.67g, 
5.97mmol) was added dropwise, maintaining the temperature below -75oC. The 
solution was allowed to warm to room temperature. Saturated aqueous NH4Cl  
solution (30ml) was added and the organic layer was isolated. The remaining aqueous 
layer was washed with Et2O (3x30ml). The organic fractions were combined, dried 
with anhydrous MgSO4 and the solvent was removed under reduced pressure. The 
crude extract was dissolved in acetonitrile (50ml) and cooled to 0oC under a nitrogen 
atmosphere. NEt3 (1.57ml, 11.2mmol) and DMAP (cat.) were added. In a separate 
flask Boc2O (2.44g, 11.2mmol) was dissolved in acetonitrile (10ml) under a nitrogen 
atmosphere. The solution was added dropwise via cannula to the previously prepared 
solution (effervescence!). The solution was allowed to warm to room temperature and 
allowed to stir for 2hr. The solvent was removed under reduced pressure. Deionized 
water (40ml) was added to the crude extract and washed with Et2O (3x40ml). The 
combined organic layers were combined and washed with saturated aqueous NH4Cl  
solution (30ml). The organic phase was dried MgSO4 and the solvent was removed 
under reduced pressure. The crude extract was dissolved in a minimal amount of 
hexanes and loaded onto a prepacked column. The column was eluted with (PE:Et2O, 
95:5), tert-butyl allyl[2-bromo-3-({[tert-
butyl(dimethyl)silyl]oxy}methyl)phenyl]carbamate was isolated as a colourless oil 
(2.25g, 88%). Rf = 0.28 (PE:Et2O, 95:5). 
 
m/z (EI+): 480, 459, 400, 318, 241, 172, 141 
 
HRMS (ESI): Calcd. for C21H34BrNO3Si [M+Na]+: 478.1384; found: 478.1387 
 
1H NMR (300 MHz, CDCl3) δ 7.04 (t, J = 7.84, 1H, H-7), 6.81 (d, J = 7.1, 1H, H-8), 
6.43 (d, J = 8.00, 1H, H-6), 5.82 (m, 1H, H-12), 5.15 (d, J = 17.2, 1H, H-13E), 5.08 
(d, J = 10.8, 1H, H-13Z), 4.57 (s, 2H, H-4), 3.64 (m, 2H, H-11),1.39 (s, 9H, H-16), 
0.97 (s, 9H, H-1), 0.04 (s, 6H, H-3). 
 
 
 
 88 
13C NMR (126 MHz, CDCl3) δ: 147.21, 145.03, 135.09, 127.83, 116.92, 116.14, 
110.78, 108.46, 85.14, 65.44, 46.87, 27.48, 26.43, 18.92, -5.023. 
  
νmax (film/cm-1): 2929, 1810, 1706, 1596, 1470, 1367. 
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2.13:	  D-­‐Methionine	  methyl	  ester	  hydrochloride.	  
 
2.12 D-Methionine (20.2g, 0.135mol) was suspended in 2,2-dimethoxypropane 
(500ml), 36% aqueous HCl (50ml) was added slowly, followed by dropwise addition 
of MeOH (ca. 10ml) until complete dissolution. The solution was allowed to stir for 
18 hours during which it had turned a dark red colour. The solvent was removed 
under reduced pressure to produce a very dark red sludge. This was dissolved in a 
minimal amount of MeOH (ca. 30ml) and transferred to a dropping funnel. Et2O 
(1000ml) was placed in a 2L conical flask equipped with a magnetic stirrer. The 
methanolic solution was added dropwise to the stirring Et2O. After complete addition 
the mixture was poured through a Buchner funnel, an off-white solid was collected 
and dissolved in a minimal amount of MeOH (ca. 20ml) and the crystallisation 
process was repeated to produce 2.13 D-methionine methyl ester hydrochloride as a 
white solid (25.14g, 93%).  
 
Physical properties and spectra comparable to that reported in the literature.48 
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2.14:	  N-­‐[(Benzyloxy)carbonyl]-­‐D-­‐methionine	  methyl	  ester.	  
1 S
2
3
4 CO2Me
NH
5
O
6
O
Ph
 
To an ice cold solution of 2.13 D-Methionine methyl ester hydrochloride (24.13g, 
0.121mol) and potassium bicarbonate (60g) in deionised water (500ml) and EtOAc 
(500ml) was added dropwise benzyl chloroformate (22.71, 0.133mol) over an hour 
period. The biphasic mixture was stirred for a further 4 hours. The organic layer was 
separated, the aqueous phase was washed with EtOAc (2x100ml) and organic phases 
were combined, washed with 1M HCl (400ml) and then with water (400ml). The 
solvent was dried with MgSO4 and removed under reduced pressure to give a 
colourless oil. The crude product was purified by column chromatography (PE, Et2O, 
1:1) followed by crystallisation from PE to give 2.14 N-[(benzyloxy)carbonyl]-D-
methionine methyl ester (30.13g, 88%) as a white solid. 
1H NMR (300 MHz, CDCl3) δ 7.36 (m, 5H, Ar-H), 5.89 (s, 1H, NH), 5.08 (s, 2H, H-
6), 4.25 (m, 1H, H-4), 3.69 (s, 3H, H-5), 2.42 (m, 2H, H-2), 2.20 (m, 2H, H-3), 1.88 
(s, 3H, H-1) 
Physical properties and spectra comparable to that reported in the literature.48 
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2.15:	  Methyl	  D-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐4-­‐(methylsulfinyl)	  
butanoate.	  
1 S
2
3
4 CO2Me
NH
5
O
6
O
Ph
O
 
To an ice cold stirring solution of sodium metaperiodate (22.74g, 0.106mol) in water 
(120ml) was added dropwise an ice cooled solution of 2.14 N-[(benzyloxy)carbonyl]-
D-methionine methyl ester (28.96g, 0.102mol) in MeOH (300ml). The reaction 
mixture was stirred for 3 hours. The precipitate was filtered off using a Buchner 
funnel and washed with MeOH (3x100ml), the filtrates were combined and 
concentrated under reduced pressure to ca. 120ml. The concentrated solution was 
washed with CHCl3 (3x150ml). The combined extracts were washed with water 
(200ml), dried with MgSO4 and concentrated under reduced pressure. Purification by 
column chromatography (CH2Cl2:MeOH, 95:5) gave 2.15 methyl D-2-
{[(benzyloxy)carbonyl]amino}-4-(methylsulfinyl) butanoate (28.14g, 92%) as a 
translucent white oil. 
 
1H NMR (300 MHz, CDCl3) δ: 7.34 (m, 5H, Ar-H), 5.91 (s, 1H, NH), 5.03 (s, 2H, H-
6), 4.34 (m, 1H, H-4), 3.67 (s, 3H, H-5), 2.90 (m, 2H, H-2), 2.51 (s, 3H, H-1) 2.30 (m, 
2H, H-3).  
 
Physical properties and spectra comparable to that reported in the literature.48 
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2.16:	  N-­‐[(benzyloxy)carbonyl]-­‐D-­‐vinylglycine	  methyl	  ester.	  
1
2
3 CO2Me
NH
4
O
5
O
Ph
 
2.15 Methyl D-2-{[(benzyloxy)carbonyl]amino}-4-(methylsulfinyl) butanoate (3.52g, 
11.8mmol) was Kugelrohr distilled at 150oC at 3mmHg. The pungent garlic smelling 
distillate was purified by column chromatography (EtOAc:PE, 15:85) as a light 
yellow oil followed by a second purifcation by column chromatography  (EtOAc:PE, 
1:9) to afford 2.16 N-[(benzyloxy)carbonyl]-D-vinylglycine methyl ester (1.57g, 
56%) as a light yellow oil. 
 
1H NMR (500 MHz, CDCl3) δ: 7.30 (m, 5H, Ar-H), 5.90 (m, 1H, H-2), 5.66 (s, 1H, 
NH), 5.36 (d, J=17Hz, 1H, H-1E), 5.26 (d, J=10.4Hz, 1H, H-1Z), 5.11 (s, 2H, H-5), 
4.95 (s, 1H, H-3), 3.74 (s, 3H, H-4).  
 
Physical properties and spectra comparable to that reported in the literature.48 
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2.25:	  Dimethyl	  (2S,3E,5S)-­‐2,5-­‐bis{[(benzyloxy)carbonyl]amino}-­‐3-­‐
hexenedioate.	  
 
432
NH
HN O
O
Ph
5O
O
6
Ph
O
O
O
O
1
 
To a stirring solution 2.16 (2R)-2-{[(benzyloxy)carbonyl]amino}-3-butenoate 
(0.608g, 2.45mmol) under a nitrogen atmosphere was added Grubbs 2nd generation 
catalyst (0.207g, 0.245mmol). The solution was refluxed for 18 hours. The solution 
was allowed to cool and the solvent was removed under reduced pressure. The dark 
brown oil was dissolved in a minimal amount of toluene (ca. 10ml) and loaded onto a 
pre-loaded column and the column was eluted with (EtOAc:PE, 1:4) to afford 2.25 
dimethyl (2S,3E,5S)-2,5-bis{[(benzyloxy)carbonyl]amino}-3-hexenedioate. 
as a light yellow oil (0.238g, 74%). 
 
m/z (ESI): 470, 462, 390, 334, 274. 
 
HRMS (ESI): Calcd. for C24H26N2O8 [M+Na]+: 493.1587 found: 493.1589 
 
1H NMR (500 MHz, CDCl3) δ: 7.45 -7.22(m, 5H, Ar-H), 5.60 (s, 1H, N-H), 5.41 (s, 
H-4), 5.19 (s, 2H, H-5), 4.95 (s, 1H, H-3), 3.74 (s, 3H, H-1). 
 
13C NMR (126 MHz, CDCl3) δ: 170.43, 155.35, 136.04, 129.44, 129.06, 128.53, 
128.24, 128.12, 67.24, 54.91, 52.88, 30.75. 
 
νmax (film/cm-1): 3328.95 w, 2953.52 w, 1722.26 s, 1698.97 s, 1641.17 m., 1524.73 s. 
. 
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2.26:Methyl	  (2S,3E)-­‐5-­‐[acetyl-­‐2-­‐bromo-­‐3-­‐({[tert-­‐
butyl(dimethyl)silyl]oxy}methyl)anilino]-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐3-­‐
pentenoate	  	  
` 
To a stirring solution of 2.10 2-bromo-3-(tert-butyldimethylsilyloxxymethyl)-N-
acetyl-N-allylaniline (0.323g, 0.813mmol) and 2.16 (2R)-2-
{[(benzyloxy)carbonyl]amino}-3-butenoate (0.405g, 1.63mmol) under a nitrogen 
atmosphere was added Grubbs 2nd generation catalyst (0.138g, 0.163mmol). The 
solution was refluxed for 18 hours. The solution was allowed to cool and the solvent 
was removed under reduced pressure. The dark brown oil was dissolved in a minimal 
amount of toluene (ca. 10ml) and loaded onto a pre-loaded column. The column was 
eluted with (PE 100%, ca. 500ml), (PE:Et2O, 1:1 ca. 500ml) and then (PE:Et2O, 3:7 
ca. 500ml) until all the product was isolated. The starting materials 2.10 2-bromo-3-
(tert-butyldimethylsilyloxxymethyl)-N-acetyl-N-allylaniline (99mg, 31%) then by  
2.16 (2R)-2-{[(benzyloxy)carbonyl]amino}-3-butenoate (0.202g, 50%) were isolated 
first followed by the desired product 2.26 methyl (2R,3E)-5-[acetyl-2-bromo-3-
({[tert-butyl(dimethyl)silyl]oxy}methyl)anilino]-2-{[(benzyloxy)carbonyl]amino}-3-
pentenoate as a light brown oil (0.332g, 66%) and finally 2.25 dimer (56.7mg, 15%). 
 
[α]D = -154.7o (c 0.19, MeOH) 
 
m/z (ESI): 620, 561, 469, 397, 299, 262, 220, 174, 149, 133, 117. 
 
HRMS (ESI): Calcd. for C29H39BrN2O6 [M+Na]+: 641.1658 found: 641.1665 
 
1H NMR (500 MHz, CDCl3) δ: 7.58 (t, J = 7.8, 1H, H-7), 7.36 (m, 6H, H-8, H-20, H-
21, H-22), 7.00 (d, J = 7.7, 1H, H-6), 5.85 (m, 1H, H-14), 5.48 (dd, J = 15.2, 6.5, 1H, 
H-15), 5.40 (s, 1H, NH), 5.12 (s, 2H, H-18), 4.85 (s, 1H, H-16), 4.75 (s, 2H, H-4), 
3.71 (s, 3H, H-24), 3.65 (dd, J = 14.3, 7.6, 2H, H-13), 1.77 (s, 3H, H-12), 0.98 (s, 9H, 
H-1), 0.16 (s, 6H, H-3). 
 
13C NMR (126 MHz, CDCl3) δ: 163.38, 166.35, 142.74, 140.81, 142.39, 137.09, 
131.30, 129.02, 128.91, 128.76, 128.52, 127.84, 128.19, 128.04, 127.99, 127.72, 
127.58, 126.81, 125.78, 122.02, 65.06, 25.92, 18.37, -5.11. 
 
νmax (film/cm-1): 3265.34 b, 1663.86 s, 1627.58 s, 1593.25 s, 1532.95 s, 1466.92 s 
 
 
 
 
 
 
 
 95 
2.28:	  Methyl	  (2S,3E)-­‐5-­‐[acetyl-­‐2-­‐bromo-­‐3-­‐(hydroxymethyl)anilino]-­‐2-­‐
{[(benzyloxy)carbonyl]amino}-­‐3-­‐pentenoate.	  
3
4
5
6
72
1HO
Br
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11
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CO2MeHN
14
O
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O
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20 21
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9 O  
Hydrofluoric acid (40%, 40 drops) was added dropwise to a stirring solution of 2.26 
methyl (2R,3E)-5-[acetyl-2-bromo-3-({[tert-
butyl(dimethyl)silyl]oxy}methyl)anilino]-2-{[(benzyloxy)carbonyl]amino}-3-
pentenoate (1.24g, 3.11mmol) in MeCN (40ml) and the solution was stirred at room 
temperature for an hour. A saturated solution of sodium bicarbonate (25ml) was 
added, the organic layer was separated and the aqueous phase was extracted with 
EtOAc (3x20ml). The organic extracts were combined, dried with magnesium 
sulphate and the solvent was removed under reduced pressure. The crude product was 
purified by column chromatography to give 2.28 methyl (2S,3E)-5-[acetyl-2-bromo-
3-(hydroxymethyl)anilino]-2-{[(benzyloxy)carbonyl]amino}-3-pentenoate (0.858g, 
97%) as a colourless oil. 
 
[α]D = -165.1o (c 0.26, MeOH) 
 
m/z (ESI): 541, 529, 248, 222, 175, 99. 
 
HRMS (ESI): Calcd. for C23H25BrN2O6 [M+Na]+: 527.0781 found: 527.0788 
 
1H NMR (500 MHz, CDCl3) δ: 7.62 (t, J = 7.8, 1H, H-4), 7.39 (m, 6H, H-5, H-17, H-
18, H-19), 7.08 (d, J = 7.7, 1H, H-3), 5.79 (m, 1H, H-11), 5.51 (dd, J = 15.2, 6.5, 1H, 
H-12), 5.38 (s, 1H, NH), 5.12 (s, 2H, H-15), 4.85 (s, 1H, H-13), 4.45 (s, 2H, H-1), 
3.82 (s, 1H, OH), 3.73 (s, 3H, H-21), 3.67 (dd, J = 14.3, 7.6, 2H, H-13), 1.77 (s, 3H, 
H-19). 
 
13C NMR (126 MHz, CDCl3) δ: 166.68, 164.51, 154.09, 143.46, 136.62, 135.57, 
135.34,128.47, 128.22, 127.94, 126.35, 124.02, 123.49, 121.27, 77.26, 77.00, 76.75, 
67.87, 52.83, 51.85, 38.17. 
 
νmax (film/cm-1): 3282 b, 1667 s, 1627 s, 1593 s, 1532 s, 1466 s 
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2.30:	  3-­‐(N-­‐Acety-­‐N-­‐allylamino)-­‐2-­‐bromobenzyl	  alcohol.	  
2
3
4
1
Br
N
OH
5
6
7
8O  
Hydrofluoric acid (40%, 40 drops) was added dropwise to a stirring solution of 2.10 
2-bromo-3-(tert-butyldimethylsilyloxymethyl)-N-acetyl-N-allylaniline (1.24g, 
3.11mmol) in MeCN (40ml) and the solution was stirred at room temperature for an 
hour. A saturated solution of sodium bicarbonate (25ml) was added, the organic layer 
was separated and the aqueous phase was extracted with EtOAc (3x20ml). The 
organic extracts were combined, dried with magnesium sulphate and the solvent was 
removed under reduced pressure. The crude product was purified by column 
chromatography to give 2.30 3-(N-Acety-N-allylamino)-2-bromobenzyl alcohol 
(0.858g, 97%) as a colourless oil. 
 
1H NMR (500 MHz, CDCl3) δ: 7.58 (d, J=7.8Hz, 1H, H-4), 7.34 (t, J=7.7Hz, 1H, H-
3), 7.09 (d, J=7.7Hz, 1H, H-2), 5.83 (m, H-6), 5.05 (d, J=10.1Hz, 1H, H-7Z), 5.00 (d 
J=17.8 Hz), 4.75 (s, 2H, H-1), 3.79 (s, 1H, OH), 3.61 (m, 2H, H-5), 1.74 (s, 1H, H-8). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.31:	  3-­‐(N-­‐Acety-­‐N-­‐allylamino)-­‐2-­‐bromobenzaldehyde.	  
2
3
4
1
Br
N
O
5
6
7
8O  
Activated manganese(IV) oxide (3.0g, 25mmol) was added to a stirring solution of 
2.30 3-(N-Acety-N-allylamino)-2-bromobenzyl alcohol (0.714g, 2.51mmol) in 
anhydrous THF and the mixture was stirred overnight. The mixture was filtered 
through a plug of Celite, the residue was washed with EtOAc (ca. 40ml). The filtrate 
and the washings were combined and the solvent was removed under reduced 
pressure to give 2.31 3-(N-acety-N-allylamino)-2-bromobenzaldehyde (0.581g, 82%) 
as a cream solid. 
 
1H NMR (500 MHz, CDCl3) δ: 10.40 (s, 1H, H-1), 7.92 (d, 7.5Hz, 1H, H-4), 7.49 (t, 
J=7.6Hz, 1H, H-3), 7.45 (d, J=7.7Hz, 1H, H-2), 5.87 (m, 1H, H-6), 5.11 (d, J=11Hz, 
H-7Z), 5.03 (d, J=17.1Hz, 1H, H-7E), 3.69 (m, 1H, H-5), 1.81 (s, 3H, H-8). 
 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.33:	  Diethyl	  2-­‐methyl-­‐2-­‐propenylphosphonate.	  
 
To a stirring suspension of methylallyl chloride (15.87g, 175mmol) and KI (29.09g, 
175mmol) in acetone:CH3CN 5:4 (875ml) was added triethyl phosphite (31.92g, 
175mmol). The mixture was stirred for 12hr at room temperature and then heated to 
60oC and stirred for a further 5hr. Filtration of the mixture through a Buchner funnel 
followed by washing of the residue with acetone (3x100ml). The filtrates were 
combined and the solvent was removed under reduced pressure to give a residue that 
was purified by Kugelhour distillation (77oC, 3mmHg) to give 2.33 diethyl 2-methyl-
2-propenylphosphonate (29.30g, 87%) as a colourless oil. 
 
1H NMR (500 MHz, CDCl3) δ: 4.84 (dd, J = 3.1, 1.5, 1H, H-3), 4.79 (d, J = 4.7, 1H, 
H-3), 4.06 – 3.97 (m, 4H, H-5), 2.49 (d, J = 22.3, 2H, H-4), 1.79 (s, 3H, 1.79), 1.23 (t, 
J = 7.1, 6H, H-6). 
 
Physical properties and spectra comparable to that reported in the literature.70 
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2.36:	  Methyl	  (2R,3E)-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐5-­‐bromo-­‐3-­‐
pentenoate.	  
 
To a solution of 2.16 methyl (2R)-2-{[(benzyloxy)carbonyl]amino}-3-butenoate 
(0.296g, 1.19mmol) and allyl bromide (1.44g, 11.9mmol) in CH2Cl2 (15ml) under a 
nitrogen atmosphere was added Grubbs 2nd generation catalyst (0.100g, 0.119mmol). 
The solution was refluxed for 18 hours. The solution was allowed to cool and the 
solvent was removed under reduced pressure. The dark brown oil was dissolved in a 
minimal amount of toluene (ca. 5ml) and loaded onto a pre-loaded column. The 
column was eluted with (PE 100%, ca. 500ml) and then (PE:EA, 17:3) to give 2.36 
Methyl (2R,3E)-2-{[(benzyloxy)carbonyl]amino}-5-bromo-3-pentenoate as an orange 
oil (0.346g, 85%). Rf =0.25 (EA:PE, 1:4). 
 
[α]D = -124.6o (c 0.67, MeOH) 
 
m/z (EI+): 282, 262, 238, 190, 157, 108, 92. 
 
HRMS (ESI): Calcd. for C14H16BrNO4 [M+Na]+: 366.0140; found: 366.0127 
 
1H NMR (500 MHz, CDCl3) δ: 7.39 – 7.31 (m, 5H, H-10, H-11, H-12), 5.98 (dt, J = 
14.8, 7.3, 1H, H-2), 5.83 (dd, J = 15.0, 4.5, 1H, H-3), 5.49 (d, J = 4.5, 1H, H-4), 5.13 
(s, 2H, H-8), 4.97 (s, 1H, NH), 3.93 (d, J = 7.1, 2H, H-1), 3.78 (s, 3H, H-6). 
 
13C NMR (126 MHz, CDCl3) δ: 170.43, 155.35, 136.04, 129.44, 129.06, 128.53, 
128.24, 128.12, 67.24, 54.91, 52.88, 30.75. 
 
νmax (film/cm-1): 3328 w, 2953  w, 1705 s, 1513 s, 1435 m. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 100 
2.38:	  2-­‐Bromo-­‐3-­‐(tert-­‐butyldimethylsilyloxymethyl)-­‐N-­‐acetylaniline.	  
4
5
6
3
Br
NH
O
O
Si
2
1
7  
To a stirring solution of 2.08 2-bromo-3-(tert-butyldimethylsilyloxymethyl)aniline 
(4.31g, 13.6mmol) in THF (130ml) was added freshly distilled acetyl chloride 
(1.94ml, 27.3mmol) was added and the solution was stirred at room temperature for 
an hour. The solution was quenched with saturated sodium bicarbonate solution 
(70ml), the organic layer was separated and the aqueous extract was washed with 
ethyl acetate (3x80ml). The organic layers were combined, dried with magnesium 
sulphate and the solvent was removed under reduced pressure. The crude extract was 
purified by column chromatography (PE:Et2O, 3:2) to give 2.38 2-bromo-3-(tert-
butyldimethylsilyloxymethyl)-N-acetylaniline (4.44g, 91%) as a light yellow oil. 
 
1H NMR (500 MHz, CDCl3) δ: 8.22 (s, 1H, H-6), 7.76 (s, 1H, NH), 7.34 (d, J = 7.7, 
1H, H-4), 7.30 (t, J = 7.9, 1H, H-5), 4.75 (s, 2H, H-3), 2.23 (s, 3H, H-5), 0.97 (s, 9H, 
H-1), 0.04 (s, 6H, H-2). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.39:	  	  3-­‐(N-­‐Acetylamino)-­‐2-­‐bromobenzyl	  alcohol.	  
2
3
4
1
Br
NH
OH
5O  
Hydrofluoric acid (40%, 80 drops) was added dropwise to a stirring solution of 2.38 
2-bromo-3-(tert-butyldimethylsilyloxymethyl)-N-acetylaniline (4.02g, 11.2mmol) in 
MeCN (100ml) and the solution was stirred at room temperature for an hour. A 
saturated solution of sodium bicarbonate (75ml) was added, the organic layer was 
separated and the aqueous phase was extracted with EtOAc (3x60ml). The organic 
extracts were combined, dried with magnesium sulphate and the solvent was removed 
under reduced pressure. The crude product was purified by column chromatography 
to give 2.39 3-(N-acetylamino)-2-bromobenzyl alcohol (2.60g, 95%) as a colourless 
oil. 
 
1H NMR (500 MHz, CDCl3) δ: 8.21 (s, 1H, H-4), 7.74 (s, 1H, NH), 7.32 (d, J = 7.5, 
1H, H-2), 7.27 (t, J = 7.9, 1H, H-3), 4.65 (s, 2H, H-1), 3.76 (s, 1H, OH), 2.20 (s, 3H, 
H-5). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.40:	  3-­‐(N-­‐Acetylamino)-­‐2-­‐bromobenzyaldehyde.	  
2
3
4
1
Br
NH
O
5O  
Activated manganese(IV) oxide (10.96g, 92.1mmol) was added to a stirring solution 
of  2.39 3-(N-acetylamino)-2-bromobenzyl alcohol (2.25g, 9.21mmol) in anhydrous 
THF (100ml) and the mixture was stirred overnight. The mixture was filtered through 
a plug of Celite, the residue was washed with EtOAc (ca. 100ml). The filtrate and the 
washings were combined and the solvent was removed under reduced pressure to give 
2.40 3-(N-Acetylamino)-2-bromobenzyaldehyde (1.96g, 88%) as a white solid. 
 
1H NMR (500 MHz, CDCl3) δ: 10.35 (s, 1H, H-1), 8.17 (s, 1H, H-4), 7.72 (s, 1H, 
NH), 7.34 (d, J = 7.6, 1H, H-2), 7.27 (t, J = 7.8, 1H, H-3), 2.23 (s, 3H, H-5). 
 
Physical properties and spectra comparable to that reported in the literature.25, 26, 27 
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2.41:	  N-­‐{2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐methyl-­‐1,3-­‐butadienyl]phenyl}acetamide.	  
 
To a solution of dimethyl 2-methyl-2-propenylphosphonate (0.600g, 3.12mmol) in 
anhydrous THF (15ml) was added nBuLi (1.6M in hexanes, 1.95ml, 3.12mmol) at -
78oC. After stirring for 15 minutes a solution of N-(2-bromo-3-
formylphenyl)acetamide (0.378g, 1.56mmol) was added in HMPA (1.05ml, 6mmol) 
was added dropwise via canular. The resulting yellow solution was stirred for 2 hours 
at -78oC. The solution was allowed to warm to room temperature and was stirred 
overnight. The solution was quenched with sauturated aqueous NH4Cl solution. The 
organic layer was isolated and the aqueous was washed with Et2O (3x15ml). The 
combined organic fractions were washed with brine (30ml), dried with MgSO4 and 
concentrated to afford a yellow oil. Purification by flash chromatography (PE:Et2O, 
3:1) yielded a white solid (0.346g, 79%). Rf = 0.34 (PE:Et2O, 3:1). 
 
m. p. = 124.9 to 125.5 oC 
 
m/z (ESI): 304, 302, 222, 166, 100. 
 
HRMS (ESI): Calcd. for C13H14NOBr [M+Na]+: 302.0150; found: 302.0143 
 
1H NMR (500 MHz, CDCl3) δ 8.19 (s, 1H, H-9), 7.74 (s, 1H, NH), 7.32 (d, J = 7.4, 
1H, H-7), 7.27 (t, J = 7.9, 1H, H-8), 6.85 (d, J = 15.9, 1H, H-5), 6.77 (d, J = 15.9, 1H, 
H-4), 5.17 (s, 1H, H-2), 5.15 (s, 1H, H-2), 2.24 (s, 3H, H-13), 2.01 (s, 3H, H-1). 
 
13C NMR (126 MHz, CDCl3) δ: 141.87, 136.01, 135.05, 127.77, 127.66, 122.29, 
120.76, 118.74, 109.98, 29.67, 24.89, 18.52. 
 
νmax (film/cm-1): 3270 m, 2920 m, 1723 w, 1660 s, 1601 m, 1585 m, 1532 s. 
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2.59:	  Methyl	  (2R,3E)-­‐5-­‐(acetyloxy)-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐3-­‐
pentenoate	  
 
 
To a solution of methyl (2R)-2-{[(benzyloxy)carbonyl]amino}-3-butenoate (1.24g, 
4.97mmol) and allyl acetate (4.98g, 49.7mmol) in CH2Cl2 (40ml) under a nitrogen 
atmosphere was added Grubbs 2nd generation catalyst (0.422g, 0.497mmol). The 
solution was refluxed for 18 hours. The solution was allowed to cool and the solvent 
was removed under reduced pressure. The dark brown oil was dissolved in a minimal 
amount of toluene (ca. 5ml) and loaded onto a pre-loaded column. The column was 
eluted with (PE 100%, ca. 500ml and then (PE:EA, 17:3) yielding methyl (2R,3E)-5-
(acetyloxy)-2-{[(benzyloxy)carbonyl]amino}-3-pentenoate as an oil (0.57g, 36%). Rf 
= 0.33 (PE:EA, 17:3). 
 
[α]D = -137.2o (c 0.72, MeOH) 
 
m/z (ESI): 344, 300, 213, 114, 99. 
 
HRMS (ESI): Calcd. for C16H19NO6 [M+Na]+: 344.1105; found: 344.1105. 
 
1H NMR (500 MHz, CDCl3) δ: 7.39 – 7.29 (m, 5H, H-12, H-13, H-14), 5.91 – 5.78 
(m, 2H, H-4, H-5), 5.54 (s, 1H, NH), 5.12 (s, 2H, H-10), 4.96 (s, 1H, H-6), 4.56 (d, J 
= 4.8, 2H, H-3), 3.76 (s, 3H, H-8), 2.05 (s, 3H, H-1). 
 
13C NMR (126 MHz, CDCl3) δ: 170.65, 170.49, 136.09, 128.51, 128.29, 128.20, 
128.15, 128.10, 128.02, 127.60, 67.16, 63.52, 55.17, 52.79, 20.80. 
 
νmax (film/cm-1): 2922.20 w, 1715.29 s, 1515.90 m, 1455.46 m. 
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2.66:	  Methyl	  2-­‐{[(benzyloxy)carbonyl]amino}-­‐2,4-­‐pentadienoate	  
 
To solution of Pd2(dba)3 (28.1mg, 0.0307mmol) and dppb (26.1mg, 0.0613mmol) in 
THF (10ml) under a nitrogen atmosphere was added via cannula a solution of 
(2R,3E)-5-(acetyloxy)-2-{[(benzyloxy)carbonyl]amino}-3-pentenoate (0.197g, 
0.613mmol) in THF (1ml), the solution was allowed to stir for ten minutes. A solution 
of N-{2-bromo-3-[(1E)-3-methyl-1,3-butadienyl]phenyl}acetamide (0.206g, 
0.736mmol) in THF (1ml) was added via cannula. The solution was heated to reflux 
for 3 hours until complete consumption of (2R,3E)-5-(acetyloxy)-2-
{[(benzyloxy)carbonyl]amino}-3-pentenoate by TLC. The solution was allowed to 
cool and filtered through Celite. The Celite was washed with Et2O (3x20ml). The 
solvent was removed under reduced pressure. The crude extract was purified by 
column chromatography to give 2-{[(benzyloxy)carbonyl]amino}-2,4-pentadienoate 
as an oil (0.125g, 78%). Rf = 0.35 (EA:PE, 1:4). 
 
HRMS (ESI): Calcd. for C14H16BrNO4 [M+Na]+: 284.0893; found: 284.0889 
 
1H NMR (500 MHz, CDCl3) δ: 7.37 (s, 5H, H-10, H-11, H-12), 7.00 (d, J = 11.2, 1H, 
H-3), 6.59 (dt, J = 17.0, 10.7, 1H, H-2), 6.41 (s, 1H, NH), 5.60 (d, J = 16.9, 1H, H-
1E), 5.48 (d, J = 10.0, 1H, H-1Z), 5.16 (s, 2H, H-8), 3.78 (s, 3H, H-6). 
 
13C NMR (126 MHz, CDCl3) δ: 165.25, 135.85, 131.46, 128.53, 128.30, 128.24, 
124.94, 110.20, 67.56, 52.54. 
 
νmax (film/cm-1): 3328 w, 2953 w, 1722 s, 1698 s, 1641 m., 1524 s. 
. 
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2.67:	  Methyl	  (2E)-­‐3-­‐{3-­‐[acetyl(allyl)amino]-­‐2-­‐bromophenyl}-­‐2-­‐propenoate	  
 
 
N-allyl-N-(2-bromo-3-formylphenyl)acetamide (2.165g, 7.62mmol) was dissolved in 
CH2Cl2 (30ml) under a nitrogen atmosphere. 2-methoxy-3-
(triphenylphosphoranylidene)propanal (3.05g, 9.14mmol) was added in portions. The 
solution was allowed to stir for 3hr at room temperature. The solvent was removed 
under reduced pressure. The white-grey solid was dissolved in a minimal amount of 
toluene and was loaded onto a pre-loaded column. The column was eluted with 
(PE:Et2O, 3:7) to give methyl (2E)-3-{3-[acetyl(allyl)amino]-2-bromophenyl}-2-
propenoate as a yellow solid (2.30g, 89%). Rf = 0.28 (PE:Et2O, 3:7). 
 
m. p. 84.9 to 86.7 oC 
 
m/z (ESI): 360, 120, 101, 58 
 
HRMS (ESI): Calcd. for C15H16BrNO3 [M+Na]+: 360.0206; found: 360.0205 
 
1H NMR (500 MHz, CDCl3) δ 8.07 (d, J = 15.9, 1H, H-4), 7.59 (dd, J = 7.9, 1.3, 1H, 
H-8), 7.37 (t, J = 7.8, 1H, H-7), 7.22 (dd, J = 7.7, 1.3, 1H, H-6), 6.40 (d, J = 15.9, 1H, 
H-3), 5.92 – 5.83 (m, 1H, H-12), 5.10 (d, J = 10.1, 1H, H-13Z), 5.05 (d, J = 17.1, 1H, 
H-13E), 3.83 (s, 3H), 3.68 – 3.62 (m, 2H, H-11), 1.80 (s, 3H, H-15). 
 
13C NMR (126 MHz, CDCl3) δ 169.79, 166.39, 142.84, 142.43, 137.11, 132.61, 
132.03,  130.33, 128.29, 127.46, 121.97, 118.69, 51.94, 50.81, 22.39. 
 
νmax (film/cm-1): 2946 m, 1718 s, 1655 s, 1567 m, 1467 m, 1431 m, 1384 s. 
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2.68	  N-­‐allyl-­‐N-­‐{2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐oxo-­‐1-­‐butenyl]phenyl}acetamide	  
 
To a stirring solution of N-allyl-N-(2-bromo-3-formylphenyl)acetamide (3.77g, 
13.4mmol) in CH2Cl2 (40ml) under nitrogen was added 1-
(triphenylphosphoranylidene)acetone (5.07g, 16.0mmol) in portions. Once the entire 
solid had dissolved the solution was stirred for 3 hours. The solvent was removed 
under reduced pressure. The grey solid was dissolved in a minimal amount of toluene 
(ca. 10ml) and loaded onto a pre-packed column. The column was eluted with 
Et2O:PE, 8:2 isolating N-allyl-N-{2-bromo-3-[(1E)-3-oxo-1-
butenyl]phenyl}acetamide (3.96g, 92%) as a yellow solid. Rf =0.32 (Et2O:PE, 8:2). 
 
m. p. = 58.9 to 60.0 oC 
 
m/z (EI): 322, 288, 242, 200, 159, 43. 
 
1H NMR (500 MHz, C6D6) δ: 7.81 (d, J = 16.3, 1H, H-4), 7.52 (dd, J = 1.3, 7.8, 1H, 
H-8), 7.30 (t, J = 7.7, 1H, H-7), 7.14 (dd, J = 1.4, 7.7, 1H, H-6), 6.54 (d, J = 16.3, 1H, 
H-3), 5.78 (dddd, J = 5.6, 7.7, 10.1, 15.8, 1H, H-12), 5.01 (d, J = 9.4, 1H, H-13E), 
4.95 (d, J = 18.3, 1H, H13Z), 3.57 (dd, J = 7.8, 14.6, 1H), 2.33 (s, 3H, H-1), 1.72 (s, 
3H, H-15). 
 
13C NMR (126 MHz, C6D6) δ 206.69, 197.73, 169.97, 169.70, 142.37, 141.34, 
137.03, 132.68, 132.46, 132.10, 130.77, 129.60, 128.31, 128.11, 128.00, 127.42, 
127.00, 118.67, 118.32, 64.83, 50.77, 50.70, 30.76, 30.21, 27.21, 22.30, 22.27. 
 
νmax (film/cm-1): 2926 w, 2668 s, 1647 s, 1568 m, 1467 m, 1414 s, 1390 s 
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2.77:	  N-­‐[2-­‐bromo-­‐3-­‐({[tert-­‐
butyl(dimethyl)silyl]oxy}methyl)phenyl]acrylamide	  
 
Acryoly chloride was freshly prepared from acrylic acid.58 2-bromo-3-({[tert-
butyl(dimethyl)silyl]oxy}methyl)aniline (5.285g, 16.8mmol) was dissolved in CH2Cl2 
(50ml), NEt3 (4.72ml, 33.6mmol) was added and the solution was cooled to 0oC. 
Acryloyl chloride was added to the stirring solution dropwise over 15 minutes, 
maintaining the temperature at 0oC. The solution was allowed to warm to room 
temperature and was stirred for 2 hours. The reaction was quenched with saturated 
aqueous sodium hydrogen carbonate. The organic layer was separated and the 
remaining aqueous extract was washed with CH2Cl2 (2x30ml) and Et2O (2x30ml). 
The organic fractions were combined and the solvent was removed under reduced 
pressure to give the crude product. Purification by column chromatography with 
(Et2O:PE, 1:3) gave N-[2-bromo-3-({[tert-
butyl(dimethyl)silyl]oxy}methyl)phenyl]acrylamide as a yellow solid (4.95g, 80%).  
Rf = 0.27 (Et2O:PE, 1:3). 
 
m. p. = 67.3 to 68.5 oC 
 
HRMS (ESI): Calcd. for C16H24BrNO2Si [M+Na]+: 392.0657; found: 392.0663 
 
1H NMR (500 MHz, CDCl3) δ: 8.30 (s, 1H, NH), 7.86 (s, 1H, H-8), 7.35 – 7.32 (m, 
2H, H-6, H-7), 6.44 (d, J = 16.8, 1H, H-13E), 6.31 (dd, J = 16.9, 10.2, 1H, H-12), 5.79 
(d, J = 10.2, 1H, H-13Z), 4.73 (s, 2H, H-4), 0.97 (s, 9H, H-1), 0.14 (s, 6H, H-3). 
 
13C NMR (126 MHz, CDCl3) δ: 163.38, 140.81, 135.09, 131.30, 127.89, 127.84, 
123.34, 122.65, 121.76, 120.68, 65.06, 25.92, 18.37, -5.11,  
 
νmax (film/cm-1): 3328 m, 2926 m, 2854 m, 1682 m, 1622 s, 1596 s, 1518 s, 1465 s. 
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2.78:	  N-­‐[2-­‐bromo-­‐3-­‐(hydroxymethyl)phenyl]acrylamide	  
 
 
N-[2-bromo-3-({[tert-butyl(dimethyl)silyl]oxy}methyl)phenyl]acrylamide (2.42g, 
6.53mmol) was dissolved in acrylonitrile (50ml). Hydrofluoric acid (ca. 20 drops) 
was added to the stirring solution at room temperature. The cloudy solution was 
stirred for 2 hours. Saturated aqueous sodium hydrogen carbonate (30ml) was added 
with care (effervescence!). The aqueous layer was separated and washed with EtOAc 
(3x20ml). The organic layers were combined and washed with saturated sodium 
chloride (30ml). The solvent was removed under reduced pressure. Purification by 
column chromatography (Et2O:PE, 9:1), to give N-[2-bromo-3-
(hydroxymethyl)phenyl]acrylamide as a white solid (1.58g, 94% yield). Rf =0.22 
(Et2O:PE, 9:1). 
 
m. p. = 136.3 to 137.2 oC. 
 
m/z (ESI): 288, 224, 178, 100. 
 
HRMS (ESI): Calcd. for C10H10BrNO2 [M+Na]+: 277.9787 found: 277.9797 
 
1H NMR (500 MHz, CDCl3) δ: 8.39 (d, J = 7.4, 1H, H-6), 7.83 (s, 1H, NH), 7.37 (t, J 
= 7.9, 1H, H-4), 7.29 (d, J = 7.4, 1H, H-3), 6.46 (d, J = 16.9, 1H, H-10E), 6.32 (dd, J 
= 16.9, 10.2, 1H, H-9), 5.84 (d, J = 10.2, 1H, H-10Z), 4.78 (d, J = 6.3, 2H, H-1), 1.55 
(s, 1H, OH). 
 
13C NMR (126 MHz, CDCl3) δ 163.32, 140.79, 135.07, 131.29, 127.88, 123.29, 
120.50, 77.24, 76.98, 76.73, 65.79, 65.05, 41.33, 34.09, 25.88, 22.57, 22.29, 20.40, 
18.36, 15.22, 14.26, 13.99, -5.38. 
 
νmax (film/cm-1): 3265 b, 1663 s, 1627 s, 1593 s, 1532 s, 1466 s 
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2.79:	  N-­‐(2-­‐bromo-­‐3-­‐formylphenyl)acrylamide	  
 
 
N-[2-bromo-3-(hydroxymethyl)phenyl]acrylamide (1.60g, 6.25mmol) was dissolved 
in THF (50ml). Manganese(IV)oxide (5.43g, 62.5mmol) was added to the stirring 
solution. The black mixture was stirred for 2hr at room temperature. The mixture was 
filtered through a cake a Celite, the plug was washed with Et2O (5x50ml). The 
yellow solution obtained was concentrated under reduced pressure to give a yellow 
oil. The crude product was purifed by column chromatography (PE:Et2O, 7:3) to give 
N-(2-bromo-3-formylphenyl)acrylamide as a white solid (1.33g, 84%). Rf = 0.33, 
(PE:Et2O, 7:3). 
 
m. p. = 129.1 to 130.3 oC. 
 
m/z (ESI): 286, 222, 176, 98. 
 
HRMS (ESI): Calcd. for C10H8BrNO2 [M+Na]+: 275.9636 found: 275.9640 
 
1H NMR (500 MHz, CDCl3) δ: 10.35 (s, 1H, H-1), 8.68 (d, J = 8.0, 1H, H-5), 7.93 (s, 
1H, NH), 7.68 (dd, J = 7.6, 1.2, 1H, H-3), 7.46 (t, J = 7.9, 1H, H-4), 6.49 (d, J = 16.9, 
1H, H-10E), 6.35 (dd, J = 16.9, 10.2, 1H, H-9), 5.87 (d, J = 10.2, 1H, H-10Z). 
 
13C NMR (126 MHz, CDCl3) δ: 191.14, 163.48, 136.43, 133.80, 130.87, 128.79, 
128.38, 127.44, 125.80, 117.74, 109.99, 77.26, 77.01, 76.75.  
 
νmax (film/cm-1): 3255 m, 3073w, 1687 s, 1661s, 1626 s, 1586 m, 1574 m, 1528 s. 
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2.80:	  Methyl	  (2E)-­‐3-­‐[3-­‐(acryloylamino)-­‐2-­‐bromophenyl]-­‐2-­‐propenoate	  
 
N-(2-bromo-3-formylphenyl)acrylamide (0.870g, 3.42mmol) was dissolved in CH2Cl2 
under nitrogen. Methyl (triphenylphosphoranylidene)acetate (1.37g, 4.11mmol) was 
added in portions to the stirring solution. Once all the phosphoranylidene had 
dissolved the solution was stirred for 3 hours at room temperature. The reaction 
mixture was concentrated under reduced pressure, dissolved in a minimal amount of 
toluene and transferred directly onto a pre-loaded silica column. The column was 
eluted with (PE:Et2O, 3:2) to give methyl (2E)-3-[3-(acryloylamino)-2-bromophenyl]-
2-propenoate as a white solid (0.85g, 86%). Rf = 0.37 (PE:Et2O, 3:2). 
 
m. p. = 84.9 to 86.7 oC 
 
HRMS (ESI): Calcd. for C13H12BrNO3 [M+Na]+: 331.9892 found: 331.9907 
 
1H NMR (500 MHz, CDCl3) δ: 8.49 (s, 1H, H-8), 8.05 (d, J = 15.8, 1H, H-4), 7.90 (s, 
1H, NH), 7.36 (m, 2H, H-6, H-7), 6.46 (d, J = 16.9, 1H, H-13E), 6.39 (d, J = 15.8, 1H, 
H-3), 6.32 (dd, J = 16.9, 10.5, 1H, H-12), 6.30 (d, J = 10.5, 1H, H-13Z), 3.83 (s, 3H, 
H-1). 
 
13C NMR (126 MHz, CDCl3) δ: 163.82, 141.58, 140.79, 136.84, 135.73, 131.65, 
128.68, 128.54, 122.11, 121.97, 120.09, 52.10 
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2.81:	  N-­‐{2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐oxo-­‐1-­‐butenyl]phenyl}acrylamide	  
 
N-(2-bromo-3-formylphenyl)acrylamide (0.32g, 1.26mmol) was dissolved in CH2Cl2 
(20ml) under a nitrogen atmosphere. 1-(triphenylphosphoranylidene)acetone (0.481g, 
1.51mmol) was added in portions to the stirring solution. Once all the 
phosphoranylidene had dissolved the solution was stirred for 3 hours at room 
temperature. The reaction mixture was concentrated under reduced pressure, 
dissolved in a minimal amount of toluene and transferred directly onto a pre-loaded 
silica column. The column was eluted with (PE:Et2O, 1:1) to give N-{2-bromo-3-
[(1E)-3-oxo-1-butenyl]phenyl}acrylamide as  a white solid (0.303g, 82%). Rf = 0.32 
(PE:Et2O, 1:1). 
 
m. p. = 167.1 to 168.3 oC. 
 
m/z (ESI): 316, 310, 152, 100. 
 
HRMS (ESI): Calcd. for C13H12BrNO2 [M+Na]+: 315.9949 found: 315.9955. 
 
1H NMR (500 MHz, CDCl3) δ: 8.50 (d, J = 6.4, 1H, H-8), 7.88 (d, J = 16.1, 1H, H-4), 
7.88 (s, 1H, NH), 7.41 – 7.35 (m, 2H, H-6, H-7), 6.64 (d, J = 16.1, 1H, H-3), 6.47 (dd, 
J = 16.9, 0.7, 1H, H-13E), 6.33 (dd, J = 16.9, 10.3, 1H, H-12), 5.86 (dd, J = 10.3, 0.7, 
1H, H-13Z), 2.42 (s, 3H, H-1). 
 
13C NMR (126 MHz, CDCl3) δ: 170.25, 141.88, 136.39, 135.21, 131.49, 130.35, 
128.32, 128.15, 122.11, 121.97, 123.34, 27.88. 
 
νmax (film/cm-1): 3255 m, 2922 s, 1683 s, 1662 s, 1609 s, 1536 s, 1468 s. 
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2.96:	  N-­‐{2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐hydroxy-­‐3-­‐methy-­‐1-­‐butenyl]phenyl}acrylamide.	  
 
N-{2-bromo-3-[(1E)-3-oxo-1-butenyl]phenyl}acrylamide (0.620g, 2.11mmol) was 
dissolved in THF (20ml) and the solution was cooled to -78oC. Methyl lithium 
(3.09ml, 4.63mmol) was added dropwise to the stirring solution maintaining the 
temperature below -75oC. Once addition was complete the solution was allowed to 
warm to room temperature. The solution was stirred for an hour at room temperature. 
Saturated aqueous ammonium chloride solution (15ml) was added to the solution and 
the organic layer was separated. The aqueous phase was washed with diethyl ether 
(3x20ml) and the organic layers were combined. The organic phase was washed with 
saturated brine solution (3x30ml). The solvent was removed under reduced pressure 
and the crude extract was purified by column chromatography (PE:Et2O, 1:1) to 
afford tertiary alcohol (0.556g, 85%). Rf = 0.36 (PE:Et2O, 1:1). 
 
m/z (EI): 311, 296, 266, 230, 214, 188, 172, 160. 
 
HRMS (ESI): Calcd. for C13H12BrNO2 [M+Na]+: 315.9949 found: 315.9955. 
 
1H NMR (500 MHz, CDCl3) δ: 8.29 (s, 1H, NH), 7.90 (s, 1H, H-8), 7.24 (s, 2H, H-7, 
H-8), 6.90 (d, J = 15.9, 1H, H-4), 6.44 (dd, J = 0.9, 16.9, 1H, H-13E), 6.31 (dd, J = 
16.9, 10.5, 1H, H-12), 6.29 (d, J = 10.5, 1H, H-13Z), 5.81 (d, 1H, J = 15.8, 1H, H-3), 
1.44 (s, 6H, H-1). 
  
13C NMR (126 MHz, CDCl3) δ: 163.42, 141.45, 140.22, 137.76, 135.73, 131.29, 
128.04, 127.80, 126.59, 125.71, 122.84, 71.05, 28.91. 
 
νmax (film/cm-1): 3240 br, 2964 m, 1662 s, 1629 s, 1589 s, 1530s. 
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2.98:	  Methyl	  2-­‐{[(benzyloxy)carbonyl]amino}-­‐5-­‐{2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐methoxy-­‐
3-­‐oxo-­‐1-­‐propenyl]anilino}-­‐5-­‐oxo-­‐2-­‐pentenoate.	  
 
To a stirring solution of methyl (2E)-3-[3-(acryloylamino)-2-bromophenyl]-2-
propenoate (0.336g, 1.08mmol) and methyl (2R)-2-{[(benzyloxy)carbonyl]amino}-3-
butenoate (0.270g, 1.08mmol) under a nitrogen atmosphere was added Grubbs 2nd 
generation catalyst (0.0919g, 0.0108mmol). The resulting brown solution was 
refluxed at 40oC for 18 hours. The solution was cooled and the solvent was removed 
under reduced pressure. The brown tar obtained was dissolved in a minimal amount 
of toluene and transferred directly onto a pre-packed silica column. The column was 
eluted with (PE, 100%), (PE:Et2O, 1:1), (PE:Et2O, 1:3), (Et2O, 100%). A green oil 
was obtained which was titriated with pentane to give a white solid (0.372g, 63%). Rf 
= 0.23 (Et2O). 
 
m. p. = 169.2 to 171.1 oC 
 
m/z (ESI): 553, 493, 413, 398, 330, 301, 279, 184, 100. 
 
HRMS (ESI): Calcd. for C24H23BrN2O7 [M+Na]+: 553.0580 found: 553.0617. 
 
1H NMR (500 MHz, CDCl3) δ: 8.49 (s, 1H, NHPh), 8.26 (d, J = 7.5, 1H, H-8), 8.05 
(d, J = 15.8, 1H, H-4), 7.40 – 7.30 (m, 6H, H-6, H-7, H-18, H-19, H-20), 6.83 (t, J = 
7.7, 1H, H-13), 6.77 (s, 1H, NHCO), 6.37 (d, J = 15.8, 1H, H-3), 5.18 (s, 2H, H-16), 
3.83 (s, 3H, H-1), 3.81 (s, 3H, H-22), 3.42 (d, J = 7.6, 2H, H-12). 
 
13C NMR (126 MHz, CDCl3) δ: 166.68, 164.51, 154.09, 143.46, 136.62, 135.57, 
135.34, 128.63, 128.47, 128.22, 127.94, 126.35, 124.02, 123.49, 121.27, 77.26, 77.00, 
76.75, 67.87, 52.83, 51.85, 38.17. 	  
νmax (film/cm-1): 3264 m, 2920 m, 1723 s, 1691 s, 1651 s, 1510 . 
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2.112:	  2-­‐Ethoxy-­‐N-­‐methylidyne-­‐2-­‐oxoethanaminium	  
 
Formate 2.111 (5.0g, 0.0382mol) was dissolved in NEt3 (26.5ml, 0.191mol) and THF 
(50ml) and was cooled to -78oC. An addition funnel was attached to the reaction and 
was charged with POCl3 (4.26ml, 0.0458mol) in THF (28ml). The solution was added 
dropwise over a period of 30mins and then allowed to stir for a further 30mins. The 
resulting red-orange solution was warmed to 0oC and allowed to stir for an additional 
hour upon which ice water (50ml) was slowly added to the solution. The organic layer 
was separated and aqueous phase was washed with Et2O (3x50ml). The organic 
extracts were combined, dried with MgSO4 and concentrated under reduced pressure 
to give a foul smelling red oil which was distilled in vacuo (85oC, ca. 5mmHg) to give 
2.112 (3.65g, 75%) as a light yellow oil. 
 
Physical properties and spectra comparable to that reported in the literature.98 
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2.113	  Potassium	  carboxy-­‐N-­‐methylidynemethanaminium	  
 
A solution of 2.112 (3.50g, 0.0306mol) and powdered KOH (1.72g, 0.0306mol) in 
THF (20ml) and distilled water (5ml) was stirred vigorously for 5 hours. The reaction 
was then concentrated and pumped on overnight to give an off white solid. The solid 
was collected with a Buchner funnel and subsequently washed with Et2O to remove 
any unreacted isocyanide. The solid was then pulverised using a pestle and mortar and 
the resulting powder was transferred to a 100ml round bottom flask and stirred with 
Et2O (50ml). The solid was then isolated on a Buchner funnel to give 2.113, (2.96g, 
78%) as an off-white solid.  
 
Mp. 164 to 165 oC. 
 
Physical properties and spectra comparable to that reported in the literature.98 
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2.114:	  Methyl	  (2R,3E)-­‐5-­‐{acetyl-­‐2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐methoxy-­‐3-­‐oxo-­‐1-­‐
propenyl]anilino}-­‐2-­‐{[(benzyloxy)carbonyl]amino}-­‐3-­‐pentenoate	  	  
 
 
To a stirring solution of methyl (2E)-3-{3-[acetyl(allyl)amino]-2-bromophenyl}-2-
propenoate (1.94g, 8.73mmol) and (2R)-2-{[(benzyloxy)carbonyl]amino}-3-
butenoate (1.42g, 8.73mmmol) under a nitrogen atmosphere was added 
dichlorodicyanoquinone (0.101g, 0.873mmol) followed by Grubbs 2nd generation 
catalyst (0.486g, 0.873mmol). The dark blue solution was refluxed for 18 hours. The 
solution was allowed to cool and a methanolic solution of polar isocyanide 2.113 was 
added and the solution was allowed to stir for 30 minutes. The solvent was removed 
under reduced pressure to give a thick dark green-blue oil that was dissolved in a 
minimal amount of toluene (ca. 15ml) and a loaded onto a pre-packed column. The 
column was eluted with 0.5L PE, 0.5L Et2O:PE (1:3), 0.5L Et2O:PE (1:1), 0.5L 
Et2O:PE (3:1) and finally Et2O until all the product was recovered. (2R)-2-
{[(benzyloxy)carbonyl]amino}-3-butenoate (0.706g) was recovered first, followed by 
methyl (2E)-3-{3-[acetyl(allyl)amino]-2-bromophenyl}-2-propenoate (0.712g), 
finally the desired product was isolated as a green oil. The product was subjected to a 
subsequent column isolating a white foam. Rf =0.34 (Et2O).  
 
[α]D = -154.6o (c 0.21, MeOH) 
 
m/z (ESI): 583, 194, 100. 
 
HRMS (ESI): Calcd. for C26H27BrN2O7 [M+Na+]: 581.089; found: 581.093. 
 
1H NMR (500 MHz, CDCl3) δ 8.06 (d, J = 15.9, 1H, H-4), 7.57 (dd, J = 8.0, 14.7, 1H, 
H-8), 7.40 – 7.30 (m, 6H, H-7, H-20, H-21, H-22), 7.10 (d, J = 9.3, 1H, H-6), 6.40 
(dd, J = 3.1, 15.9, 1H, H-3), 5.84 (m, 1H, H-14), 5.51 (dd, J = 5.7, 18.3, 1H, H-15), 
5.43 (s, 1H, NH), 5.12 (s, 2H, H-18), 4.85 (m, 1H, H-16), 3.84 (s, 3H, H-1), 3.72 (s, 
3H, H-24), 3.64 (m, 2H, H-13), 1.79 (s, 3H, H-12). 
 
13C NMR (126 MHz, CDCl3) δ 169.98, 166.35, 142.74, 142.46, 142.39, 137.09, 
132.25, 130.30, 129.02, 128.91, 128.52, 128.39, 128.19, 128.04, 127.99, 127.72, 
127.58, 126.81, 122.02, 67.01, 55.08, 52.68, 51.94, 51.46, 49.07, 29.64, 22.31. 
 
νmax (film/cm-1): 2952 w, 1714 s , 1659 s, 1522 m, 1434 m, 1390 m 
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  2.115:	  Methyl	  (2R,3E)-­‐5-­‐{acetyl-­‐2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐oxo-­‐1-­‐	  butenyl]anilino}-­‐2-­‐
{[(benzyloxy)carbonyl]amino}-­‐3-­‐pentenoate	  
 
 
To a stirring solution of N-allyl-N-{2-bromo-3-[(1E)-3-oxo-1-
butenyl]phenyl}acetamide (1.08g, 3.35mmol) and (2R)-2-
{[(benzyloxy)carbonyl]amino}-3-butenoate (1.25g, 5.03mmmol) under a nitrogen 
atmosphere was added dichlorodicyanoquinone (88.9mg, 0.503mmol) followed by 
Grubbs 2nd generation catalyst (0.426g, 0.503mmol). The dark blue solution was 
heated to reflux for 18 hours. The solution was allowed to cool and a methanolic 
solution of polar isocyanide 2.113 was added and the solution was allowed to stir for 
30 minutes. The solvent was removed under reduced pressure to give a thick dark 
green-blue oil that was dissolved in a minimal amount of toluene (ca. 15ml) and 
transferred onto a pre-packed column. The column was eluted with 0.5L PE, 0.5L 
Et2O:PE (1:3), 0.5L Et2O:PE (1:1), 0.5L Et2O:PE (3:1) and finally Et2O until all the 
product was recovered. (2R)-2-{[(benzyloxy)carbonyl]amino}-3-butenoate (0.313g, 
25%) was recovered first, followed by N-allyl-N-{2-bromo-3-[(1E)-3-oxo-1-
butenyl]phenyl}acetamide (0.432g, 40%), then dimer (0.150g, 20%)finally the 
desired product methyl (2R,3E)-5-{acetyl-2-bromo-3-[(1E)-3-oxo-1-butenyl]anilino}-
2-{[(benzyloxy)carbonyl]amino}-3-pentenoate was isolated as a dark green oil. The 
product was subjected to a subsequent column isolating as a yellow oil (1.00g, 55%). 
Rf =0.28 (Et2O).  
 
[α]D = -147.1o (c 0.23, MeOH) 
 
 
HRMS (ESI): Calcd. for C26H27BrN2NaO6 [M+Na]+: 565.0950; found: 565.0912 
 
1H NMR (500 MHz, CDCl3) δ 7.89 (d, J = 16.3, 1H, H-4), 7.59 (dd, J = 7.8, 14.2, 1H, 
H-8), 7.40 – 7.29 (m, 6H, H-7, H-18, H-19, H-20), 7.12 (d, J = 7.4, 1H, H-6), 6.62 
(dd, J = 3.7, 16.3, 1H, H-3), 5.94 – 5.77 (m, 1H, H-12), 5.51 (dd, J = 5.7, 18.3, 1H, H-
13), 5.45 (m, 1H, H-14), 5.43 (s, 1H, NH), 5.12 (d, J = 2.6, 2H, H-16), 4.85 (m, 1H, 
H-14), 3.72 (s, 3H, H-22), 3.68 – 3.61 (m, 2H, H-11), 2.43 (s, 3H, H-1), 1.76 (s, 3H, 
H-24). 
 
13C NMR (126 MHz, CDCl3) δ 197.77, 169.74, 142.02, 141.98, 141.33, 137.14, 
132.42, 130.89, 129.08, 128.97, 128.55, 128.53, 128.48, 128.42, 128.38, 128.24, 
128.21, 128.05, 128.01, 127.67, 127.61, 127.57, 127.05, 127.01, 77.25, 76.99, 76.74, 
67.09, 55.24, 55.06, 52.71, 48.95, 48.92, 29.66, 27.33, 27.32, 22.34, 22.32. 
 
νmax (film/cm-1): 2926 w, 2668 s, 1647 s, 1568 m, 1467 m, 1414 s,  1390 s. 
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2.116:	  Methyl	  1-­‐acetyl-­‐1,2,2a,3,4,5-­‐hexahydrobenzo[cd]indole-­‐4-­‐carboxylate	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A glass syringe filled with a solution of AIBN (0.022g) and Bu3SnH (0.566g, 
1.95mmol) in toluene (50ml) connected to syringe pump equipped with a long needle 
was cautiously inserted through a suba-seal placed in the top of the reflux condenser 
connected to a flask containing a stirring solution of methyl (2E)-3-{3-
[acetyl(allyl)amino]-2-bromophenyl}-2-propenoate (0.470g, 1.39mmol) and AIBN 
(0.011g) in toluene (20ml) at reflux. Once the entire solution had been added the 
reaction the syringe was removed and the solution was refluxed for 18hrs. The 
solution was concentrated under reduced pressure and the white residue was purified 
by column chromatography (MeOH:CH2Cl2, 1:99) to a give a white solid which was 
triturated with diethyl ether producing 2.116 methyl 1-acetyl-1,2,2a,3,4,5-
hexahydrobenzo[cd]indole-4-carboxylate (0.256g, 71%). Rf =0.22 (MeOH:CH2Cl2, 
1:99) 
 
m/z (ESI): 282, 257, 140. 
 
HRMS (ESI): Calcd. for C15H17N1O3[M+Na+]: 282.1101; found: 282.1106. 
 
1H NMR (500 MHz, CDCl3) δ: 7.84 (d, J = 7.8, 1H, H-9) 7.15 (t, J = 7.8, 1H, H-8), 
6.84 (d, J = 7.7, 1H, H-7), 4.24 (t, J = 9.2, 1H, H-1α), 3.76 (s, 3H, H-15), 3.61 (t, J = 
10.5, 1H, H-1β), 3.45 – 3.33 (m, 1H, H-2β), 3.15 (dd, J = 16.6, 6.2, 1H, H-5β), 2.91 
(dd, J = 16.7, 11.6, 1H, H-5α), 2.47 (d, J = 11.3, 1H, H-4β), 2.47 (d, J = 11.9 Hz, H-
3β), 2.23 (s, 3H, H-13), 1.49 (dd, J = 15.7, 8.0 Hz, H-3α). 
 
13C NMR (126 MHz, CDCl3) δ: 175.36, 168.42, 141.65, 130.76, 129.05, 128.46, 
122.75, 114.25, 77.26, 77.01, 76.75, 68.49, 56.65, 51.96, 40.53, 38.73, 37.35, 31.90, 
30.31, 29.67, 29.36, 28.65, 23.88, 23.16, 22.66, 14.07, 10.98. 
 
νmax (film/cm-1): 2953 w, 1740 s , 1714 m, 1651 s, 1461 s, 1403 s. 
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2.117:	  Methyl	  (2R,3E)-­‐5-­‐{acetyl-­‐2-­‐bromo-­‐3-­‐[(1E)-­‐3-­‐oxo-­‐1-­‐butenyl]anilino}-­‐2-­‐
{[(benzyloxy)carbonyl]amino}-­‐3-­‐pentenoate.	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A glass syringe filled with a solution of AIBN (0.031g) and Bu3SnH (0.771g, 
2.65mmol) in toluene (60ml) connected to syringe pump equipped with a long needle 
was cautiously inserted through a suba-seal placed in the top of the reflux condenser 
connected to a flask containing a stirring solution of N-allyl-N-{2-bromo-3-[(1E)-3-
oxo-1-butenyl]phenyl}acetamide (0.610g, 1.89mmol) and AIBN (0.016g) in toluene 
(35ml) at reflux. Once the entire solution had been added the reaction the syringe was 
removed and the solution was refluxed for 18hrs. The solution was concentrated 
under reduced pressure and the white residue was purified by column chromatography 
(MeOH:CH2Cl2, 1:150) to a give a white solid which was triturated with diethyl ether 
producing 2.117 methyl (2R,3E)-5-{acetyl-2-bromo-3-[(1E)-3-oxo-1-
butenyl]anilino}-2-{[(benzyloxy)carbonyl]amino}-3-pentenoate (0.336g, 73%). Rf 
=0.25 (MeOH:CH2Cl2, 1:150).  
 
HRMS (ESI): Calcd. for C15H17NO2[M+Na+]: 266.1157; found: 266.1151 
 
1H NMR (500 MHz, CDCl3) δ: 7.84 (d, J = 7.8, 1H, H-9), 7.15 (t, J = 7.8, 1H, H-8), 
6.85 (d, J = 7.7, 1H, H-7), 4.25 (t, J = 9.2, 1H, H-1α), 3.61 (t, J = 10.5, 1H, H-1β), 
3.41 (dd, J = 11.7,11.4 Hz, 1H, H-4β), 3.25 (m, 1H, H-2β), 3.09 (dd, J = 6.1, 16.7, 
1H, H-5β), 2.83 (dd, J = 16.7, 11.4 Hz, 1H, H-4β) 2.40 (dd, J = 12.2, 9.2 Hz, 1H, H-
3β,), 2.28 (s, 3H, H-15), 2.23 (s, 3H, H-13), 1.49 (q, J = 11.7 Hz, 1H, H-3α). 
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  A	  
 
Table 1.  Crystal data and structure refinement . 
Identification code  mar1108 
Empirical formula  C24 H26 N2 O8 
Formula weight  470.47 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  C2  (No.5) 
Unit cell dimensions a = 28.9290(17) Å α= 90°. 
 b = 4.7732(2) Å β= 106.735(2)°. 
 c = 17.8927(10) Å γ = 90°. 
Volume 2366.1(2) Å3 
Z 4 
Density (calculated) 1.32 Mg/m3 
Absorption coefficient 0.10 mm-1 
F(000) 992 
Crystal size 0.40 x 0.05 x 0.02 mm3 
Theta range for data collection 3.44 to 25.95°. 
Index ranges -35<=h<=28, -5<=k<=5, -18<=l<=22 
Reflections collected 8452 
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Independent reflections 2545 [R(int) = 0.047] 
Reflections with I>2sigma(I) 2148 
Completeness to theta = 25.95° 98.1 %  
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2545 / 1 / 317 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.039, wR2 = 0.081 
R indices (all data) R1 = 0.053, wR2 = 0.087 
Largest diff. peak and hole 0.15 and -0.19 e.Å-3 
The H atoms on N were refined. 
 
Data collection KappaCCD , Program package WinGX , Abs correction not applied,  
Refinement using SHELXL-97 , Drawing using ORTEP-3 for Windows  
 130 
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for mar1108.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
O(1) 4839(1) 258(4) 2716(1) 32(1) 
O(2) 4544(1) -3484(4) 3202(1) 37(1) 
O(3) 3832(1) -835(6) 4864(1) 58(1) 
O(4) 4334(1) 2473(5) 4674(1) 51(1) 
O(5) 2116(1) 4424(4) 1002(1) 40(1) 
O(6) 2339(1) 8244(4) 1752(1) 40(1) 
O(7) 2024(1) 2336(7) 3319(2) 84(1) 
O(8) 2374(1) 5817(6) 4085(1) 57(1) 
N(1) 4223(1) 869(5) 3193(1) 30(1) 
N(2) 2508(1) 3875(5) 2245(1) 32(1) 
C(1) 4006(1) 476(7) 4439(2) 37(1) 
C(2) 3859(1) 39(6) 3563(1) 31(1) 
C(3) 3390(1) 1510(6) 3160(1) 28(1) 
C(4) 3160(1) 3328(5) 3475(1) 28(1) 
C(5) 2687(1) 4728(6) 3051(1) 29(1) 
C(6) 2319(1) 4139(7) 3482(2) 37(1) 
C(7) 4486(1) 3080(12) 5506(2) 74(1) 
C(8) 2028(1) 5516(11) 4537(2) 71(1) 
C(9) 4535(1) -1014(6) 3053(1) 27(1) 
C(10) 5188(1) -1561(6) 2510(2) 37(1) 
C(11) 5483(1) 312(6) 2159(2) 35(1) 
C(12) 5297(1) 1395(8) 1415(2) 48(1) 
C(13) 5562(1) 3220(9) 1106(2) 63(1) 
C(14) 6022(1) 3979(8) 1533(2) 62(1) 
C(15) 6208(1) 2900(9) 2256(2) 67(1) 
C(16) 5942(1) 1083(8) 2570(2) 53(1) 
C(17) 2321(1) 5724(6) 1679(1) 28(1) 
C(18) 1887(1) 6200(6) 335(1) 43(1) 
C(19) 1578(1) 4272(6) -268(1) 34(1) 
C(20) 1730(1) 3351(7) -891(2) 41(1) 
C(21) 1455(1) 1435(7) -1417(2) 49(1) 
C(22) 1028(1) 435(7) -1325(2) 49(1) 
C(23) 869(1) 1398(8) -715(2) 49(1) 
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C(24) 1144(1) 3301(7) -189(2) 41(1) 
________________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for mar1108. 
_____________________________________________________ 
O(1)-C(9)  1.346(3) 
O(1)-C(10)  1.457(3) 
O(2)-C(9)  1.207(3) 
O(3)-C(1)  1.202(3) 
O(4)-C(1)  1.325(4) 
O(4)-C(7)  1.455(3) 
O(5)-C(17)  1.338(3) 
O(5)-C(18)  1.457(3) 
O(6)-C(17)  1.210(3) 
O(7)-C(6)  1.187(4) 
O(8)-C(6)  1.316(3) 
O(8)-C(8)  1.463(4) 
N(1)-C(9)  1.346(3) 
N(1)-C(2)  1.453(3) 
N(2)-C(17)  1.335(3) 
N(2)-C(5)  1.443(3) 
C(1)-C(2)  1.515(4) 
C(2)-C(3)  1.514(4) 
C(3)-C(4)  1.314(4) 
C(4)-C(5)  1.515(3) 
C(5)-C(6)  1.511(4) 
C(10)-C(11)  1.493(4) 
C(11)-C(16)  1.371(4) 
C(11)-C(12)  1.384(4) 
C(12)-C(13)  1.378(5) 
C(13)-C(14)  1.379(5) 
C(14)-C(15)  1.352(5) 
C(15)-C(16)  1.382(5) 
C(18)-C(19)  1.502(4) 
C(19)-C(20)  1.381(4) 
C(19)-C(24)  1.385(4) 
C(20)-C(21)  1.387(4) 
C(21)-C(22)  1.377(5) 
C(22)-C(23)  1.380(4) 
C(23)-C(24)  1.382(4) 
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C(9)-O(1)-C(10) 115.8(2) 
C(1)-O(4)-C(7) 116.4(3) 
C(17)-O(5)-C(18) 116.7(2) 
C(6)-O(8)-C(8) 116.9(3) 
C(9)-N(1)-C(2) 121.0(2) 
C(17)-N(2)-C(5) 121.5(2) 
O(3)-C(1)-O(4) 124.6(3) 
O(3)-C(1)-C(2) 122.5(3) 
O(4)-C(1)-C(2) 112.9(2) 
N(1)-C(2)-C(3) 108.9(2) 
N(1)-C(2)-C(1) 114.1(2) 
C(3)-C(2)-C(1) 112.1(2) 
C(4)-C(3)-C(2) 126.6(2) 
C(3)-C(4)-C(5) 124.8(2) 
N(2)-C(5)-C(6) 110.7(2) 
N(2)-C(5)-C(4) 112.9(2) 
C(6)-C(5)-C(4) 109.3(2) 
O(7)-C(6)-O(8) 123.5(3) 
O(7)-C(6)-C(5) 124.8(3) 
O(8)-C(6)-C(5) 111.6(2) 
O(2)-C(9)-N(1) 125.7(2) 
O(2)-C(9)-O(1) 124.3(2) 
N(1)-C(9)-O(1) 110.0(2) 
O(1)-C(10)-C(11) 105.7(2) 
C(16)-C(11)-C(12) 117.6(3) 
C(16)-C(11)-C(10) 121.2(3) 
C(12)-C(11)-C(10) 121.2(3) 
C(13)-C(12)-C(11) 121.0(3) 
C(12)-C(13)-C(14) 120.3(3) 
C(15)-C(14)-C(13) 119.0(3) 
C(14)-C(15)-C(16) 120.9(3) 
C(11)-C(16)-C(15) 121.2(3) 
O(6)-C(17)-N(2) 125.5(2) 
O(6)-C(17)-O(5) 123.5(2) 
N(2)-C(17)-O(5) 111.0(2) 
O(5)-C(18)-C(19) 105.5(2) 
C(20)-C(19)-C(24) 118.9(3) 
C(20)-C(19)-C(18) 120.9(3) 
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C(24)-C(19)-C(18) 120.1(2) 
C(19)-C(20)-C(21) 120.3(3) 
C(22)-C(21)-C(20) 120.4(3) 
C(21)-C(22)-C(23) 119.5(3) 
C(22)-C(23)-C(24) 120.1(3) 
C(23)-C(24)-C(19) 120.7(3) 
_____________________________________________________________ 
 
 
 Hydrogen bonds with  H..A < r(A) + 2.000 Angstroms  and  <DHA > 110 
deg. 
  
 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
  
 N1-H1X         0.87     1.99    169       2.849    O2 [ x, y+1, z ] 
  
 N2-H2X         0.89     1.95    168       2.828    O6 [ x, y-1, z ] 
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Table 1.  Crystal data and structure refinement . 
Identification code  feb1908 
Empirical formula  C14 H16 Br N O2 
Formula weight  310.19 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P   (No.2) 
Unit cell dimensions a = 9.3923(4) Å α= 100.511(2)°. 
 b = 9.9224(4) Å β= 102.992(2)°. 
 c = 16.4652(5) Å γ = 92.468(2)°. 
Volume 1464.42(10) Å3 
Z 4 
Density (calculated) 1.41 Mg/m3 
Absorption coefficient 2.80 mm-1 
F(000) 632 
Crystal size 0.30 x 0.30 x 0.25 mm3 
Theta range for data collection 3.47 to 25.89°. 
Index ranges -11<=h<=11, -12<=k<=12, -20<=l<=20 
Reflections collected 23899 
 136 
Independent reflections 5656 [R(int) = 0.072] 
Reflections with I>2sigma(I) 4054 
Completeness to theta = 25.89° 99.3 %  
Tmax. and Tmin.  0.476 and 0.401 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 5656 / 0 / 325 
Goodness-of-fit on F2 1.120 
Final R indices [I>2sigma(I)] R1 = 0.074, wR2 = 0.242 
R indices (all data) R1 = 0.106, wR2 = 0.258 
Largest diff. peak and hole 1.49 and -0.72 e.Å-3   (near Br) 
There are two independent molecules with essentially the same geometry. 
The hydroxyl H atoms are disordered over two sites. 
 
Data collection KappaCCD , Program package WinGX , Abs correction MULTISCAN  
Refinement using SHELXL-97 , Drawing using ORTEP-3 for Windows  
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for feb1908.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
Br 5181(1) 1170(1) 2963(1) 47(1) 
O(1) 5960(8) 5878(7) 4695(4) 55(2) 
O(2) 723(6) -1406(6) 919(4) 45(2) 
N 3056(7) -411(7) 1366(4) 33(2) 
C(1) 3606(8) 1865(8) 2258(5) 32(2) 
C(2) 3345(9) 3259(9) 2463(5) 33(2) 
C(3) 2125(10) 3684(9) 1950(6) 42(2) 
C(4) 1274(10) 2818(9) 1246(6) 41(2) 
C(5) 1586(9) 1458(9) 1039(5) 36(2) 
C(6) 2751(8) 967(8) 1552(5) 31(2) 
C(7) 4252(9) 4224(9) 3206(5) 38(2) 
C(8) 4375(10) 5580(10) 3297(5) 42(2) 
C(9) 5262(11) 6582(10) 4047(6) 46(2) 
C(10) 4265(12) 7559(12) 4420(8) 67(3) 
C(11) 6448(12) 7385(11) 3779(7) 53(2) 
C(12) 2051(8) -1506(9) 1067(5) 34(2) 
C(13) 2666(10) -2862(9) 924(6) 43(2) 
C(14) 1806(12) -4004(10) 606(6) 50(2) 
Br(1B) 10353(1) 7324(1) 2805(1) 47(1) 
O(1B) 10959(8) 3963(8) 4693(4) 61(2) 
O(2B) 5804(7) 8661(7) 1212(6) 65(2) 
N(1B) 8042(7) 7876(7) 1312(5) 37(2) 
C(1B) 8627(9) 6163(8) 2199(5) 33(2) 
C(2B) 8322(9) 4938(9) 2448(5) 36(2) 
C(3B) 6997(10) 4168(9) 2004(5) 39(2) 
C(4B) 6076(10) 4579(9) 1333(6) 40(2) 
C(5B) 6420(9) 5790(9) 1093(5) 37(2) 
C(6B) 7686(9) 6601(8) 1525(5) 33(2) 
C(7B) 9248(9) 4495(9) 3184(6) 40(2) 
C(8B) 9233(10) 3237(10) 3328(6) 44(2) 
C(9B) 10155(10) 2773(10) 4094(6) 43(2) 
C(10B) 11225(13) 1821(12) 3817(7) 60(3) 
C(11B) 9160(14) 2068(15) 4522(8) 77(4) 
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C(12B) 7098(9) 8842(9) 1187(6) 37(2) 
C(13B) 7721(10) 10119(9) 1010(6) 41(2) 
C(14B) 6872(12) 11070(10) 775(6) 50(2) 
________________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for feb1908. 
_____________________________________________________ 
Br-C(1)  1.903(8) 
O(1)-C(9)  1.432(11) 
O(2)-C(12)  1.228(10) 
N-C(12)  1.350(10) 
N-C(6)  1.402(10) 
C(1)-C(6)  1.390(11) 
C(1)-C(2)  1.408(11) 
C(2)-C(3)  1.393(12) 
C(2)-C(7)  1.475(12) 
C(3)-C(4)  1.370(12) 
C(4)-C(5)  1.391(12) 
C(5)-C(6)  1.389(11) 
C(7)-C(8)  1.324(13) 
C(8)-C(9)  1.492(12) 
C(9)-C(10)  1.521(14) 
C(9)-C(11)  1.532(14) 
C(12)-C(13)  1.488(12) 
C(13)-C(14)  1.314(13) 
Br(1B)-C(1B)  1.909(8) 
O(1B)-C(9B)  1.449(12) 
O(2B)-C(12B)  1.231(10) 
N(1B)-C(12B)  1.346(11) 
N(1B)-C(6B)  1.418(11) 
C(1B)-C(2B)  1.390(12) 
C(1B)-C(6B)  1.404(11) 
C(2B)-C(3B)  1.404(12) 
C(2B)-C(7B)  1.473(12) 
C(3B)-C(4B)  1.379(12) 
C(4B)-C(5B)  1.380(12) 
C(5B)-C(6B)  1.377(12) 
C(7B)-C(8B)  1.313(13) 
C(8B)-C(9B)  1.520(12) 
C(9B)-C(10B)  1.497(14) 
C(9B)-C(11B)  1.510(14) 
C(12B)-C(13B)  1.477(12) 
C(13B)-C(14B)  1.317(13) 
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C(12)-N-C(6) 125.8(7) 
C(6)-C(1)-C(2) 122.2(7) 
C(6)-C(1)-Br 118.3(6) 
C(2)-C(1)-Br 119.5(6) 
C(3)-C(2)-C(1) 116.6(8) 
C(3)-C(2)-C(7) 120.6(8) 
C(1)-C(2)-C(7) 122.7(7) 
C(4)-C(3)-C(2) 121.9(8) 
C(3)-C(4)-C(5) 120.3(8) 
C(6)-C(5)-C(4) 120.0(8) 
C(5)-C(6)-C(1) 118.8(7) 
C(5)-C(6)-N 120.8(7) 
C(1)-C(6)-N 120.4(7) 
C(8)-C(7)-C(2) 125.3(8) 
C(7)-C(8)-C(9) 126.5(9) 
O(1)-C(9)-C(8) 110.5(8) 
O(1)-C(9)-C(10) 107.9(8) 
C(8)-C(9)-C(10) 109.6(8) 
O(1)-C(9)-C(11) 108.6(8) 
C(8)-C(9)-C(11) 109.7(8) 
C(10)-C(9)-C(11) 110.5(9) 
O(2)-C(12)-N 123.2(8) 
O(2)-C(12)-C(13) 121.7(8) 
N-C(12)-C(13) 115.1(7) 
C(14)-C(13)-C(12) 121.2(8) 
C(12B)-N(1B)-C(6B) 124.4(7) 
C(2B)-C(1B)-C(6B) 122.2(8) 
C(2B)-C(1B)-Br(1B) 119.5(6) 
C(6B)-C(1B)-Br(1B) 118.2(6) 
C(1B)-C(2B)-C(3B) 116.5(8) 
C(1B)-C(2B)-C(7B) 123.2(8) 
C(3B)-C(2B)-C(7B) 120.1(8) 
C(4B)-C(3B)-C(2B) 121.7(8) 
C(3B)-C(4B)-C(5B) 120.3(8) 
C(6B)-C(5B)-C(4B) 120.2(8) 
C(5B)-C(6B)-C(1B) 119.0(8) 
C(5B)-C(6B)-N(1B) 121.4(7) 
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C(1B)-C(6B)-N(1B) 119.6(7) 
C(8B)-C(7B)-C(2B) 125.5(9) 
C(7B)-C(8B)-C(9B) 126.0(9) 
O(1B)-C(9B)-C(10B) 109.0(8) 
O(1B)-C(9B)-C(11B) 108.8(9) 
C(10B)-C(9B)-C(11B) 110.7(10) 
O(1B)-C(9B)-C(8B) 109.3(8) 
C(10B)-C(9B)-C(8B) 109.7(8) 
C(11B)-C(9B)-C(8B) 109.3(8) 
O(2B)-C(12B)-N(1B) 122.0(8) 
O(2B)-C(12B)-C(13B) 122.8(8) 
N(1B)-C(12B)-C(13B) 115.2(7) 
C(14B)-C(13B)-C(12B) 120.9(9) 
_____________________________________________________________ 
 
Hydrogen bonds with  H..A < r(A) + 2.000 Angstroms  and  <DHA > 110 
deg. 
  
 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
  
O1-H1XA        0.853    1.976   179.19    2.830    O1B_a [ -x+2, -
y+1, -z+1 ] 
O1-H1XB        0.849    2.064   179.54    2.912    O1 [ -x+1, -y+1, -
z+1 ] 
  
N-H0           0.880    1.988   158.79    2.826    O2B_a [ x, y-1, z 
] 
  
O1B-H1BX_a     0.852    1.978   179.18    2.830    O1 [ -x+2, -y+1, -
z+1 ] 
O1B-H1BY_a     0.850    2.130   179.49    2.980    O1B_a [ -x+2, -
y+1, -z+1 ] 
  
N1B-H1B1_a     0.880    1.966   167.16    2.831    O2 [ x+1, y+1, z ] 
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